| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.994 | 0.001 | 0.994 | Protein kinase C delta inhibitor | |||
| 0.62 | 0.033 | 0.674 | Caspase 9 stimulant | 0.674 0.027 DBMET02012 0.427 0.095 DBMET02013 | DBMET02012 | |
| 0.525 | 0.005 | 0.833 | Alpha-N-acetylglucosaminidase inhibitor | 0.799 0.002 DBMET02012 0.833 0.002 DBMET02013 | DBMET02013 | |
| 0.484 | 0.004 | 0.484 | Topoisomerase I inhibitor | 0.104 0.067 DBMET02012 | ||
| 0.499 | 0.033 | 0.61 | 5 Hydroxytryptamine release inhibitor | 0.61 0.01 DBMET02012 0.454 0.05 DBMET02013 | DBMET02012 | |
| 0.492 | 0.028 | 0.598 | GABA C receptor rho-3 antagonist | 0.598 0.008 DBMET02012 0.449 0.042 DBMET02013 | DBMET02012 | |
| 0.465 | 0.038 | 0.76 | Aldehyde oxidase inhibitor | 0.76 0.005 DBMET02012 0.672 0.01 DBMET02013 | DBMET02012 | |
| 0.426 | 0.017 | 0.426 | Calcium channel activator | 0.383 0.031 DBMET02012 0.282 0.111 DBMET02013 | ||
| 0.452 | 0.046 | 0.527 | Immunosuppressant | 0.527 0.026 DBMET02012 0.438 0.051 DBMET02013 | DBMET02012 | |
| 0.438 | 0.038 | 0.625 | 5 Hydroxytryptamine release stimulant | 0.625 0.012 DBMET02012 0.318 0.064 DBMET02013 | DBMET02012 | |
| 0.456 | 0.058 | 0.456 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.45 0.062 DBMET02012 0.419 0.085 DBMET02013 | ||
| 0.403 | 0.008 | 0.681 | Tyrosine 3 hydroxylase inhibitor | 0.681 0.003 DBMET02012 0.334 0.02 DBMET02013 | DBMET02012 | |
| 0.394 | 0.015 | 0.54 | 5 Hydroxytryptamine uptake stimulant | 0.54 0.004 DBMET02012 0.273 0.061 DBMET02013 | DBMET02012 | |
| 0.382 | 0.005 | 0.736 | GABA C receptor agonist | 0.736 0.002 DBMET02012 0.406 0.005 DBMET02013 | DBMET02012 | |
| 0.373 | 0.004 | 0.373 | GABA C receptor antagonist | 0.372 0.004 DBMET02012 0.182 0.017 DBMET02013 | ||
| 0.357 | 0.004 | 0.357 | GABA C receptor rho-2 antagonist | 0.272 0.008 DBMET02012 0.187 0.037 DBMET02013 | ||
| 0.412 | 0.07 | 0.592 | Histamine release inhibitor | 0.592 0.011 DBMET02012 0.389 0.082 DBMET02013 | DBMET02012 | |
| 0.347 | 0.009 | 0.347 | Neurotrophic factor enhancer | 0.292 0.02 DBMET02012 0.246 0.041 DBMET02013 | ||
| 0.367 | 0.031 | 0.505 | Hypolipemic | 0.505 0.012 DBMET02012 | DBMET02012 | |
| 0.433 | 0.099 | 0.433 | Apoptosis agonist | 0.324 0.156 DBMET02012 | ||
| 0.359 | 0.027 | 0.58 | Peroxidase inhibitor | 0.58 0.005 DBMET02012 0.411 0.019 DBMET02013 | DBMET02012 | |
| 0.381 | 0.054 | 0.653 | Cholesterol antagonist | 0.653 0.012 DBMET02012 0.356 0.062 DBMET02013 | DBMET02012 | |
| 0.343 | 0.032 | 0.403 | DNA synthesis inhibitor | 0.386 0.023 DBMET02012 0.403 0.021 DBMET02013 | DBMET02013 | |
| 0.318 | 0.015 | 0.318 | Protein kinase stimulant | 0.296 0.017 DBMET02012 0.18 0.05 DBMET02013 | ||
| 0.355 | 0.058 | 0.355 | Caspase 3 stimulant | 0.238 0.124 DBMET02013 | ||
| 0.285 | 0.003 | 0.285 | Antineoplastic alkaloid | 0.093 0.052 DBMET02012 | ||
| 0.303 | 0.023 | 0.324 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.324 0.017 DBMET02012 0.199 0.073 DBMET02013 | DBMET02012 | |
| 0.283 | 0.004 | 0.283 | GABA C receptor rho-1 antagonist | 0.283 0.004 DBMET02012 0.152 0.02 DBMET02013 | ||
| 0.285 | 0.013 | 0.778 | Succinate dehydrogenase inhibitor | 0.778 0.002 DBMET02012 0.604 0.002 DBMET02013 | DBMET02012 | |
| 0.311 | 0.041 | 0.311 | Antimitotic | |||
| 0.301 | 0.031 | 0.323 | RNA-directed DNA polymerase inhibitor | 0.323 0.028 DBMET02012 0.248 0.05 DBMET02013 | DBMET02012 | |
| 0.272 | 0.006 | 0.383 | Phosphofructokinase-1 inhibitor | 0.383 0.003 DBMET02012 0.373 0.004 DBMET02013 | DBMET02012 | |
| 0.265 | 0.011 | 0.265 | 5 Hydroxytryptamine 3E antagonist | 0.19 0.08 DBMET02012 0.21 0.048 DBMET02013 | ||
| 0.303 | 0.056 | 0.321 | DNA damaging | 0.321 0.05 DBMET02012 | DBMET02012 | |
| 0.258 | 0.015 | 0.258 | DNA intercalator | |||
| 0.271 | 0.027 | 0.352 | Lipocortins synthesis antagonist | 0.352 0.013 DBMET02012 | DBMET02012 | |
| 0.265 | 0.024 | 0.265 | Nitric-oxide synthase stimulant | 0.26 0.026 DBMET02012 0.22 0.06 DBMET02013 | ||
| 0.279 | 0.039 | 0.509 | Anesthetic general | 0.509 0.007 DBMET02012 0.273 0.041 DBMET02013 | DBMET02012 | |
| 0.253 | 0.013 | 0.253 | ATPase inhibitor | 0.201 0.037 DBMET02012 0.211 0.029 DBMET02013 | ||
| 0.26 | 0.023 | 0.26 | Topoisomerase II inhibitor | |||
| 0.258 | 0.026 | 0.428 | Amylase inhibitor | 0.288 0.02 DBMET02012 0.428 0.008 DBMET02013 | DBMET02013 | |
| 0.256 | 0.025 | 0.256 | 3C-like protease (Human coronavirus) inhibitor | 0.151 0.099 DBMET02012 0.21 0.046 DBMET02013 | ||
| 0.277 | 0.051 | 0.355 | Cyclic AMP phosphodiesterase inhibitor | 0.355 0.024 DBMET02012 | DBMET02012 | |
| 0.307 | 0.081 | 0.592 | Apoptosis antagonist | 0.592 0.01 DBMET02012 0.354 0.054 DBMET02013 | DBMET02012 | |
| 0.24 | 0.015 | 0.637 | Ferrochelatase inhibitor | 0.637 0.001 DBMET02012 0.278 0.01 DBMET02013 | DBMET02012 | |
| 0.238 | 0.014 | 0.437 | UDP-glucose 4-epimerase inhibitor | 0.298 0.01 DBMET02012 0.437 0.004 DBMET02013 | DBMET02013 | |
| 0.235 | 0.013 | 0.235 | Microtubule formation inhibitor | 0.21 0.018 DBMET02012 0.178 0.026 DBMET02013 | ||
| 0.304 | 0.084 | 0.371 | Vasodilator, coronary | 0.371 0.046 DBMET02012 0.314 0.077 DBMET02013 | DBMET02012 | |
| 0.254 | 0.041 | 0.36 | Non-steroidal antiinflammatory agent | 0.36 0.018 DBMET02012 0.214 0.061 DBMET02013 | DBMET02012 | |
| 0.242 | 0.03 | 0.302 | Interferon gamma antagonist | 0.302 0.019 DBMET02012 0.174 0.054 DBMET02013 | DBMET02012 | |
| 0.326 | 0.117 | 0.402 | Antibacterial | 0.402 0.076 DBMET02012 0.353 0.1 DBMET02013 | DBMET02012 | |
| 0.3 | 0.094 | 0.389 | Transcription factor NF kappa B inhibitor | 0.389 0.066 DBMET02012 0.305 0.092 DBMET02013 | DBMET02012 | |
| 0.219 | 0.013 | 0.43 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.43 0.003 DBMET02012 0.202 0.015 DBMET02013 | DBMET02012 | |
| 0.266 | 0.062 | 0.368 | Gastrin inhibitor | 0.368 0.007 DBMET02012 0.255 0.073 DBMET02013 | DBMET02012 | |
| 0.219 | 0.018 | 0.265 | Arachidonic acid antagonist | 0.265 0.004 DBMET02012 0.223 0.015 DBMET02013 | DBMET02012 | |
| 0.293 | 0.093 | 0.486 | Antithrombotic | 0.486 0.031 DBMET02012 0.345 0.066 DBMET02013 | DBMET02012 | |
| 0.264 | 0.066 | 0.593 | Superoxide dismutase inhibitor | 0.544 0.009 DBMET02012 0.593 0.007 DBMET02013 | DBMET02013 | |
| 0.262 | 0.07 | 0.446 | Interleukin agonist | 0.446 0.013 DBMET02012 0.281 0.058 DBMET02013 | DBMET02012 | |
| 0.199 | 0.011 | 0.537 | Triose-phosphate isomerase inhibitor | 0.512 0.002 DBMET02012 0.537 0.002 DBMET02013 | DBMET02013 | |
| 0.188 | 0.005 | 0.214 | Ca2+-transporting ATPase inhibitor | 0.214 0.003 DBMET02012 0.186 0.005 DBMET02013 | DBMET02012 | |
| 0.197 | 0.016 | 0.396 | Catalase inhibitor | 0.396 0.004 DBMET02012 0.377 0.004 DBMET02013 | DBMET02012 | |
| 0.185 | 0.007 | 0.895 | Alcohol oxidase inhibitor | 0.885 0.002 DBMET02012 0.895 0.002 DBMET02013 | DBMET02013 | |
| 0.213 | 0.04 | 0.333 | Diuretic | 0.333 0.018 DBMET02012 | DBMET02012 | |
| 0.199 | 0.027 | 0.293 | Cholesterol synthesis inhibitor | 0.293 0.012 DBMET02012 0.268 0.015 DBMET02013 | DBMET02012 | |
| 0.188 | 0.017 | 0.402 | Adenylate kinase inhibitor | 0.402 0.003 DBMET02012 0.343 0.005 DBMET02013 | DBMET02012 | |
| 0.179 | 0.008 | 0.179 | Acetylcholine M3 receptor agonist | |||
| 0.19 | 0.02 | 0.19 | Beta amyloid protein antagonist | 0.138 0.05 DBMET02012 | ||
| 0.178 | 0.01 | 0.216 | Keratolytic | 0.216 0.007 DBMET02012 0.106 0.027 DBMET02013 | DBMET02012 | |
| 0.178 | 0.013 | 0.29 | NADH dehydrogenase inhibitor | 0.29 0.007 DBMET02012 0.197 0.011 DBMET02013 | DBMET02012 | |
| 0.22 | 0.054 | 0.305 | Hepatoprotectant | 0.305 0.028 DBMET02012 0.166 0.093 DBMET02013 | DBMET02012 | |
| 0.192 | 0.03 | 0.621 | Aldehyde dehydrogenase inhibitor | 0.368 0.007 DBMET02012 0.621 0.004 DBMET02013 | DBMET02013 | |
| 0.193 | 0.033 | 0.285 | Cell wall synthesis inhibitor | 0.285 0.011 DBMET02012 0.145 0.07 DBMET02013 | DBMET02012 | |
| 0.177 | 0.02 | 0.199 | Vanilloid 1 agonist | 0.199 0.012 DBMET02012 0.15 0.038 DBMET02013 | DBMET02012 | |
| 0.166 | 0.01 | 0.456 | Carbamoyl phosphate synthetase inhibitor | 0.456 0.003 DBMET02012 0.26 0.005 DBMET02013 | DBMET02012 | |
| 0.162 | 0.005 | 0.168 | Glycine receptor antagonist | 0.168 0.005 DBMET02012 0.085 0.049 DBMET02013 | DBMET02012 | |
| 0.246 | 0.09 | 0.249 | Transcription factor STAT inhibitor | 0.249 0.088 DBMET02012 | DBMET02012 | |
| 0.16 | 0.009 | 0.183 | Ornithine decarboxylase inhibitor | 0.183 0.005 DBMET02012 0.133 0.017 DBMET02013 | DBMET02012 | |
| 0.157 | 0.006 | 0.157 | ATPase (Vacuolar H+) inhibitor | 0.093 0.05 DBMET02012 | ||
| 0.164 | 0.013 | 0.178 | Interleukin 1 beta converting enzyme inhibitor | 0.178 0.009 DBMET02012 0.168 0.011 DBMET02013 | DBMET02012 | |
| 0.212 | 0.063 | 0.212 | Nitric oxide antagonist | 0.154 0.091 DBMET02012 0.194 0.069 DBMET02013 | ||
| 0.181 | 0.033 | 0.233 | Alkylator | 0.233 0.019 DBMET02012 0.17 0.037 DBMET02013 | DBMET02012 | |
| 0.249 | 0.102 | 0.27 | Hypoxia-inducible factor 1 alpha inhibitor | 0.27 0.083 DBMET02012 | DBMET02012 | |
| 0.181 | 0.035 | 0.181 | CF transmembrane conductance regulator agonist | 0.179 0.037 DBMET02012 0.141 0.093 DBMET02013 | ||
| 0.16 | 0.013 | 0.181 | Anabolic | 0.181 0.007 DBMET02012 0.133 0.029 DBMET02013 | DBMET02012 | |
| 0.246 | 0.1 | 0.366 | Insulysin inhibitor | 0.366 0.029 DBMET02012 0.241 0.106 DBMET02013 | DBMET02012 | |
| 0.151 | 0.007 | 0.239 | Glycine receptor agonist | 0.239 0.003 DBMET02012 0.12 0.013 DBMET02013 | DBMET02012 | |
| 0.174 | 0.031 | 0.206 | Cyclooxygenase 3 inhibitor | 0.206 0.017 DBMET02012 0.128 0.069 DBMET02013 | DBMET02012 | |
| 0.161 | 0.02 | 0.325 | Creatine kinase inhibitor | 0.325 0.004 DBMET02012 0.208 0.009 DBMET02013 | DBMET02012 | |
| 0.147 | 0.005 | 0.156 | Granulocyte macrophage colony stimulating factor agonist | 0.156 0.005 DBMET02012 0.125 0.013 DBMET02013 | DBMET02012 | |
| 0.16 | 0.018 | 0.712 | Porphobilinogen synthase inhibitor | 0.712 0.002 DBMET02012 0.231 0.009 DBMET02013 | DBMET02012 | |
| 0.156 | 0.016 | 0.156 | Interleukin 2 antagonist | |||
| 0.188 | 0.048 | 0.257 | Interleukin 6 antagonist | 0.257 0.022 DBMET02012 0.146 0.096 DBMET02013 | DBMET02012 | |
| 0.151 | 0.012 | 0.151 | Interleukin 12 antagonist | 0.1 0.054 DBMET02012 | ||
| 0.235 | 0.096 | 0.261 | Transcription factor STAT3 inhibitor | 0.261 0.075 DBMET02012 | DBMET02012 | |
| 0.171 | 0.033 | 0.283 | Cystathionine beta-synthase inhibitor | 0.283 0.011 DBMET02012 0.161 0.036 DBMET02013 | DBMET02012 | |
| 0.239 | 0.101 | 0.383 | Immunostimulant | 0.383 0.055 DBMET02012 0.33 0.07 DBMET02013 | DBMET02012 | |
| 0.17 | 0.035 | 0.274 | Adenylate cyclase stimulant | 0.274 0.003 DBMET02012 0.175 0.03 DBMET02013 | DBMET02012 | |
| 0.183 | 0.049 | 0.241 | Melanin inhibitor | 0.241 0.03 DBMET02012 0.214 0.036 DBMET02013 | DBMET02012 | |
| 0.256 | 0.123 | 0.651 | Vasodilator, peripheral | 0.651 0.01 DBMET02012 0.227 0.147 DBMET02013 | DBMET02012 | |
| 0.137 | 0.004 | 0.137 | Exportin-1 inhibitor | 0.106 0.007 DBMET02012 0.08 0.025 DBMET02013 | ||
| 0.231 | 0.1 | 0.407 | Spasmolytic | 0.407 0.039 DBMET02012 0.159 0.155 DBMET02013 | DBMET02012 | |
| 0.181 | 0.053 | 0.278 | Phospholipase A2 inhibitor | 0.278 0.017 DBMET02012 0.227 0.03 DBMET02013 | DBMET02012 | |
| 0.164 | 0.037 | 0.202 | Cathepsin H inhibitor | 0.202 0.022 DBMET02012 0.18 0.029 DBMET02013 | DBMET02012 | |
| 0.157 | 0.032 | 0.178 | Heat shock protein 70 antagonist | 0.178 0.013 DBMET02012 0.138 0.081 DBMET02013 | DBMET02012 | |
| 0.146 | 0.021 | 0.294 | Electrolyte absorption antagonist | 0.294 0.004 DBMET02012 0.131 0.029 DBMET02013 | DBMET02012 | |
| 0.142 | 0.019 | 0.142 | CYP2A6 inhibitor | 0.078 0.05 DBMET02012 | ||
| 0.133 | 0.011 | 0.247 | Acyl-CoA dehydrogenase inhibitor | 0.247 0.003 DBMET02012 0.165 0.008 DBMET02013 | DBMET02012 | |
| 0.125 | 0.003 | 0.125 | DNA gyrase subunit A inhibitor | |||
| 0.139 | 0.017 | 0.139 | Glutamate (mGluR7) agonist | 0.137 0.018 DBMET02012 | ||
| 0.144 | 0.024 | 0.253 | Prolactin inhibitor | 0.253 0.004 DBMET02012 0.154 0.02 DBMET02013 | DBMET02012 | |
| 0.175 | 0.055 | 0.259 | Neurotensin receptor agonist | 0.259 0.019 DBMET02012 0.147 0.109 DBMET02013 | DBMET02012 | |
| 0.148 | 0.029 | 0.214 | Carbonic anhydrase III inhibitor | 0.214 0.014 DBMET02012 0.099 0.063 DBMET02013 | DBMET02012 | |
| 0.15 | 0.031 | 0.15 | DNA repair enzyme inhibitor | 0.135 0.048 DBMET02012 0.108 0.101 DBMET02013 | ||
| 0.122 | 0.003 | 0.216 | Glucose-6-phosphate isomerase inhibitor | 0.2 0.002 DBMET02012 0.216 0.001 DBMET02013 | DBMET02013 | |
| 0.129 | 0.012 | 0.129 | Caspase 7 inhibitor | 0.111 0.019 DBMET02012 0.096 0.033 DBMET02013 | ||
| 0.142 | 0.026 | 0.212 | DOPA decarboxylase inhibitor | 0.212 0.005 DBMET02012 0.167 0.014 DBMET02013 | DBMET02012 | |
| 0.151 | 0.037 | 0.277 | Aminopeptidase B inhibitor | 0.277 0.01 DBMET02012 0.23 0.016 DBMET02013 | DBMET02012 | |
| 0.12 | 0.005 | 0.12 | Potassium channel Kv1.3 blocker | 0.045 0.035 DBMET02012 | ||
| 0.148 | 0.034 | 0.281 | Mucolytic | 0.281 0.005 DBMET02012 0.164 0.025 DBMET02013 | DBMET02012 | |
| 0.133 | 0.02 | 0.152 | Lanosterol 14 alpha demethylase inhibitor | 0.152 0.01 DBMET02012 0.095 0.063 DBMET02013 | DBMET02012 | |
| 0.147 | 0.033 | 0.293 | Photosensitizer | 0.293 0.004 DBMET02012 0.176 0.019 DBMET02013 | DBMET02012 | |
| 0.257 | 0.144 | 0.35 | Calpain 2 inhibitor | 0.325 0.099 DBMET02012 0.35 0.087 DBMET02013 | DBMET02013 | |
| 0.13 | 0.02 | 0.483 | Glutamate dehydrogenase inhibitor | 0.483 0.003 DBMET02012 0.18 0.012 DBMET02013 | DBMET02012 | |
| 0.145 | 0.035 | 0.161 | Protein kinase C gamma inhibitor | 0.161 0.026 DBMET02013 | DBMET02013 | |
| 0.123 | 0.013 | 0.341 | Biliverdin reductase inhibitor | 0.341 0.003 DBMET02012 0.147 0.01 DBMET02013 | DBMET02012 | |
| 0.119 | 0.011 | 0.119 | Acetylcholine M5 receptor agonist | 0.06 0.055 DBMET02012 | ||
| 0.122 | 0.015 | 0.122 | Na+ K+ transporting ATPase inhibitor | 0.115 0.02 DBMET02012 0.118 0.018 DBMET02013 | ||
| 0.13 | 0.023 | 0.313 | Histidine decarboxylase inhibitor | 0.313 0.006 DBMET02012 0.137 0.022 DBMET02013 | DBMET02012 | |
| 0.217 | 0.112 | 0.217 | 5 Hydroxytryptamine 1E antagonist | 0.172 0.164 DBMET02012 | ||
| 0.12 | 0.015 | 0.377 | Argininosuccinate synthase inhibitor | 0.377 0.003 DBMET02012 0.25 0.005 DBMET02013 | DBMET02012 | |
| 0.173 | 0.069 | 0.437 | Phospholipase C inhibitor | 0.437 0.008 DBMET02012 0.213 0.037 DBMET02013 | DBMET02012 | |
| 0.108 | 0.006 | 0.108 | RNA-directed RNA polymerase stimulant | |||
| 0.188 | 0.086 | 0.34 | Insulin sensitizer | 0.34 0.01 DBMET02012 0.17 0.108 DBMET02013 | DBMET02012 | |
| 0.119 | 0.018 | 0.119 | mTOR complex 2 inhibitor | 0.089 0.048 DBMET02012 0.077 0.076 DBMET02013 | ||
| 0.108 | 0.007 | 0.385 | Aconitate hydratase inhibitor | 0.385 0.002 DBMET02012 0.138 0.005 DBMET02013 | DBMET02012 | |
| 0.119 | 0.021 | 0.432 | Glutamate decarboxylase inhibitor | 0.432 0.003 DBMET02012 0.314 0.003 DBMET02013 | DBMET02012 | |
| 0.156 | 0.059 | 0.245 | Mannose-6-phosphate isomerase inhibitor | 0.216 0.023 DBMET02012 0.245 0.013 DBMET02013 | DBMET02013 | |
| 0.105 | 0.009 | 0.256 | Glutamate (mGluR6) antagonist | 0.256 0.002 DBMET02012 0.103 0.009 DBMET02013 | DBMET02012 | |
| 0.136 | 0.041 | 0.302 | Expectorant | 0.302 0.008 DBMET02012 0.145 0.037 DBMET02013 | DBMET02012 | |
| 0.135 | 0.041 | 0.193 | Caspase 3 inhibitor | 0.19 0.011 DBMET02012 0.193 0.011 DBMET02013 | DBMET02013 | |
| 0.113 | 0.02 | 0.346 | Phenylalanine 4-hydroxylase inhibitor | 0.346 0.004 DBMET02012 0.163 0.01 DBMET02013 | DBMET02012 | |
| 0.143 | 0.052 | 0.205 | Anesthetic local | 0.205 0.031 DBMET02012 0.128 0.061 DBMET02013 | DBMET02012 | |
| 0.098 | 0.008 | 0.098 | Nicotinic alpha3beta2 receptor antagonist | 0.055 0.033 DBMET02012 0.051 0.04 DBMET02013 | ||
| 0.181 | 0.092 | 0.47 | Psychostimulant | 0.47 0.014 DBMET02012 0.196 0.082 DBMET02013 | DBMET02012 | |
| 0.215 | 0.126 | 0.307 | Lipoxygenase inhibitor | 0.307 0.068 DBMET02012 | DBMET02012 | |
| 0.102 | 0.013 | 0.102 | Protein kinase C beta inhibitor | 0.093 0.017 DBMET02013 | ||
| 0.102 | 0.013 | 0.102 | Protein 50S ribosomal subunit inhibitor | 0.083 0.018 DBMET02012 0.092 0.015 DBMET02013 | ||
| 0.129 | 0.041 | 0.139 | Carbonic anhydrase XV inhibitor | 0.139 0.035 DBMET02012 0.108 0.057 DBMET02013 | DBMET02012 | |
| 0.201 | 0.113 | 0.251 | Calpain inhibitor | 0.248 0.067 DBMET02012 0.251 0.064 DBMET02013 | DBMET02013 | |
| 0.118 | 0.03 | 0.118 | Topoisomerase II alpha inhibitor | 0.082 0.051 DBMET02013 | ||
| 0.124 | 0.037 | 0.226 | HIV-1 integrase (Overall Integration) inhibitor | 0.226 0.007 DBMET02012 0.124 0.037 DBMET02013 | DBMET02012 | |
| 0.132 | 0.046 | 0.186 | TRPA1 agonist | 0.186 0.014 DBMET02012 0.179 0.016 DBMET02013 | DBMET02012 | |
| 0.104 | 0.019 | 0.104 | Transforming growth factor beta 3 antagonist | |||
| 0.094 | 0.009 | 0.094 | Aldosterone antagonist | 0.063 0.018 DBMET02012 | ||
| 0.131 | 0.047 | 0.131 | 5 Hydroxytryptamine 3A agonist | |||
| 0.087 | 0.003 | 0.087 | Tubulin agonist | |||
| 0.098 | 0.015 | 0.249 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.156 0.008 DBMET02012 0.249 0.005 DBMET02013 | DBMET02013 | |
| 0.15 | 0.068 | 0.169 | Hemostatic | 0.169 0.049 DBMET02012 | DBMET02012 | |
| 0.093 | 0.011 | 0.093 | Potassium channel intermediate-conductance Ca-activated blocker | 0.069 0.027 DBMET02012 | ||
| 0.11 | 0.031 | 0.139 | Bile acid receptor antagonist | 0.139 0.01 DBMET02012 0.095 0.061 DBMET02013 | DBMET02012 | |
| 0.106 | 0.027 | 0.106 | Nicotinic alpha4beta2 receptor antagonist | 0.084 0.046 DBMET02013 | ||
| 0.139 | 0.061 | 0.25 | Toll-Like receptor 2 antagonist | 0.25 0.009 DBMET02012 0.179 0.034 DBMET02013 | DBMET02012 | |
| 0.109 | 0.031 | 0.207 | Glutamate release inhibitor | 0.207 0.004 DBMET02012 0.096 0.049 DBMET02013 | DBMET02012 | |
| 0.103 | 0.026 | 0.242 | Aminopeptidase I inhibitor | 0.242 0.005 DBMET02012 0.145 0.013 DBMET02013 | DBMET02012 | |
| 0.094 | 0.018 | 0.094 | Protease 3C (Human rhinovirus) inhibitor | 0.091 0.02 DBMET02012 0.094 0.018 DBMET02013 | ||
| 0.093 | 0.018 | 0.1 | Androgen agonist | 0.1 0.014 DBMET02012 | DBMET02012 | |
| 0.08 | 0.006 | 0.08 | Caspase 2 inhibitor | 0.073 0.007 DBMET02012 0.036 0.018 DBMET02013 | ||
| 0.084 | 0.01 | 0.185 | Alpha-mannosidase inhibitor | 0.121 0.005 DBMET02012 0.185 0.003 DBMET02013 | DBMET02013 | |
| 0.085 | 0.011 | 0.085 | Potassium channel (Inward rectifier) blocker | |||
| 0.107 | 0.035 | 0.132 | Carbonic anhydrase XIII inhibitor | 0.132 0.026 DBMET02012 0.124 0.028 DBMET02013 | DBMET02012 | |
| 0.141 | 0.071 | 0.163 | Pregnane X receptor agonist | 0.163 0.034 DBMET02012 0.141 0.072 DBMET02013 | DBMET02012 | |
| 0.123 | 0.054 | 0.123 | Transcription factor STAT6 inhibitor | 0.113 0.073 DBMET02012 | ||
| 0.073 | 0.004 | 0.073 | Guanylate cyclase inhibitor | 0.072 0.004 DBMET02012 0.057 0.014 DBMET02013 | ||
| 0.09 | 0.022 | 0.09 | Phosphodiesterase VIII inhibitor | |||
| 0.097 | 0.029 | 0.139 | Estrogen-related receptor beta agonist | 0.139 0.005 DBMET02012 0.131 0.006 DBMET02013 | DBMET02012 | |
| 0.097 | 0.029 | 0.24 | GABA aminotransferase inhibitor | 0.24 0.004 DBMET02012 0.104 0.024 DBMET02013 | DBMET02012 | |
| 0.118 | 0.051 | 0.128 | Acetylcholine release stimulant | 0.128 0.037 DBMET02012 0.114 0.058 DBMET02013 | DBMET02012 | |
| 0.078 | 0.012 | 0.078 | Mineralocorticoid receptor antagonist | |||
| 0.07 | 0.004 | 0.07 | HMG CoA reductase inhibitor | 0.067 0.004 DBMET02012 | ||
| 0.087 | 0.021 | 0.087 | Potassium channel (Tandem pore domain) blocker | 0.081 0.032 DBMET02012 | ||
| 0.116 | 0.052 | 0.116 | MAO B inhibitor | |||
| 0.141 | 0.078 | 0.217 | Sphingosine 1-phosphate receptor 5 antagonist | 0.217 0.006 DBMET02012 0.156 0.052 DBMET02013 | DBMET02012 | |
| 0.126 | 0.063 | 0.27 | Adenylate cyclase inhibitor | 0.27 0.017 DBMET02012 0.111 0.075 DBMET02013 | DBMET02012 | |
| 0.106 | 0.044 | 0.106 | Antineoplastic antibiotic | 0.077 0.059 DBMET02012 | ||
| 0.072 | 0.01 | 0.072 | Cholesterol esterase inhibitor | 0.05 0.029 DBMET02012 | ||
| 0.069 | 0.007 | 0.069 | Microtubule stabilization | 0.053 0.023 DBMET02012 | ||
| 0.072 | 0.011 | 0.166 | Mannosidase inhibitor | 0.121 0.005 DBMET02012 0.166 0.004 DBMET02013 | DBMET02013 | |
| 0.061 | 0.003 | 0.061 | Potassium channel (Inward rectifier) 1 blocker | |||
| 0.065 | 0.008 | 0.065 | Acetylcholine M4 receptor agonist | |||
| 0.069 | 0.012 | 0.069 | Potassium channel (Inward rectifier) activator | 0.053 0.03 DBMET02012 | ||
| 0.092 | 0.036 | 0.163 | Interferon agonist | 0.163 0.009 DBMET02012 0.143 0.011 DBMET02013 | DBMET02012 | |
| 0.086 | 0.03 | 0.126 | Vanilloid 4 agonist | 0.126 0.005 DBMET02012 0.08 0.04 DBMET02013 | DBMET02012 | |
| 0.07 | 0.014 | 0.07 | Squalene epoxidase inhibitor | 0.063 0.018 DBMET02012 0.063 0.018 DBMET02013 | ||
| 0.081 | 0.026 | 0.124 | Glutamate (mGluR7) antagonist | 0.124 0.004 DBMET02012 0.072 0.039 DBMET02013 | DBMET02012 | |
| 0.077 | 0.022 | 0.077 | Phosphodiesterase 1C inhibitor | 0.058 0.053 DBMET02012 | ||
| 0.08 | 0.025 | 0.164 | Purinergic P2X1 antagonist | 0.164 0.005 DBMET02012 0.093 0.019 DBMET02013 | DBMET02012 | |
| 0.071 | 0.016 | 0.071 | Topoisomerase II beta inhibitor | 0.05 0.032 DBMET02012 | ||
| 0.066 | 0.012 | 0.066 | Potassium channel (ATP-sensitive) activator | 0.05 0.029 DBMET02012 | ||
| 0.096 | 0.042 | 0.166 | Glutathione S-transferase inhibitor | 0.166 0.009 DBMET02012 0.111 0.028 DBMET02013 | DBMET02012 | |
| 0.075 | 0.023 | 0.331 | Ornithine carbamoyltransferase inhibitor | 0.269 0.005 DBMET02012 0.331 0.004 DBMET02013 | DBMET02013 | |
| 0.085 | 0.034 | 0.094 | MAP kinase kinase 7 inhibitor | 0.09 0.025 DBMET02012 0.094 0.019 DBMET02013 | DBMET02013 | |
| 0.117 | 0.067 | 0.142 | Proteasome inhibitor | 0.132 0.057 DBMET02012 0.142 0.051 DBMET02013 | DBMET02013 | |
| 0.064 | 0.015 | 0.071 | Adenylate cyclase 1 inhibitor | 0.071 0.011 DBMET02012 0.06 0.018 DBMET02013 | DBMET02012 | |
| 0.097 | 0.049 | 0.121 | Androgen antagonist | 0.121 0.033 DBMET02012 | DBMET02012 | |
| 0.122 | 0.073 | 0.122 | MAO inhibitor | |||
| 0.059 | 0.011 | 0.442 | Fumarate hydratase inhibitor | 0.442 0.002 DBMET02012 0.07 0.008 DBMET02013 | DBMET02012 | |
| 0.056 | 0.008 | 0.124 | Glutamate (mGluR8) agonist | 0.124 0.002 DBMET02012 0.062 0.006 DBMET02013 | DBMET02012 | |
| 0.135 | 0.088 | 0.22 | Thiol protease inhibitor | 0.18 0.048 DBMET02012 0.22 0.033 DBMET02013 | DBMET02013 | |
| 0.055 | 0.009 | 0.128 | Kainate receptor agonist | 0.128 0.002 DBMET02012 0.053 0.011 DBMET02013 | DBMET02012 | |
| 0.074 | 0.029 | 0.113 | Interferon inducer | 0.113 0.009 DBMET02012 0.083 0.021 DBMET02013 | DBMET02012 | |
| 0.067 | 0.022 | 0.084 | Ryanodine receptor antagonist | 0.084 0.007 DBMET02012 | DBMET02012 | |
| 0.065 | 0.021 | 0.094 | Pregnane X receptor antagonist | 0.094 0.004 DBMET02012 0.072 0.012 DBMET02013 | DBMET02012 | |
| 0.136 | 0.093 | 0.136 | MAP kinase 3 inhibitor | |||
| 0.095 | 0.052 | 0.107 | Calcium antagonist | 0.107 0.043 DBMET02012 | DBMET02012 | |
| 0.126 | 0.083 | 0.213 | Sphingosine 1-phosphate receptor 2 antagonist | 0.213 0.005 DBMET02012 0.136 0.063 DBMET02013 | DBMET02012 | |
| 0.136 | 0.095 | 0.201 | Hexokinase inhibitor | 0.185 0.045 DBMET02012 0.201 0.035 DBMET02013 | DBMET02013 | |
| 0.067 | 0.028 | 0.067 | Phosphodiesterase 1A inhibitor | |||
| 0.148 | 0.108 | 0.376 | Platelet adhesion inhibitor | 0.376 0.014 DBMET02012 0.139 0.12 DBMET02013 | DBMET02012 | |
| 0.091 | 0.052 | 0.166 | Interleukin 5 antagonist | 0.133 0.017 DBMET02012 0.166 0.008 DBMET02013 | DBMET02013 | |
| 0.063 | 0.025 | 0.072 | Dihydroorotate oxidase inhibitor | 0.072 0.016 DBMET02012 0.06 0.029 DBMET02013 | DBMET02012 | |
| 0.085 | 0.047 | 0.114 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.114 0.031 DBMET02012 0.095 0.04 DBMET02013 | DBMET02012 | |
| 0.056 | 0.018 | 0.061 | Cytokine production stimulant | 0.061 0.012 DBMET02012 0.055 0.019 DBMET02013 | DBMET02012 | |
| 0.08 | 0.042 | 0.183 | GABA B receptor agonist | 0.183 0.004 DBMET02012 0.111 0.01 DBMET02013 | DBMET02012 | |
| 0.077 | 0.039 | 0.128 | Phospholipase D inhibitor | 0.128 0.005 DBMET02012 0.08 0.034 DBMET02013 | DBMET02012 | |
| 0.078 | 0.041 | 0.093 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.093 0.019 DBMET02012 0.068 0.065 DBMET02013 | DBMET02012 | |
| 0.103 | 0.067 | 0.153 | AMP-activated protein kinase stimulant | 0.153 0.026 DBMET02012 | DBMET02012 | |
| 0.079 | 0.044 | 0.136 | CDC25A inhibitor | 0.136 0.015 DBMET02012 | DBMET02012 | |
| 0.07 | 0.036 | 0.131 | NMDA receptor glycine site agonist | 0.131 0.006 DBMET02012 0.065 0.041 DBMET02013 | DBMET02012 | |
| 0.05 | 0.017 | 0.088 | Dopamine D5 agonist | 0.088 0.005 DBMET02012 0.042 0.025 DBMET02013 | DBMET02012 | |
| 0.073 | 0.042 | 0.195 | Sphingosine 1-phosphate receptor 4 agonist | 0.195 0.004 DBMET02012 0.102 0.024 DBMET02013 | DBMET02012 | |
| 0.084 | 0.052 | 0.143 | Carbonic anhydrase VI inhibitor | 0.143 0.022 DBMET02012 0.077 0.061 DBMET02013 | DBMET02012 | |
| 0.048 | 0.017 | 0.076 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.076 0.004 DBMET02012 0.053 0.012 DBMET02013 | DBMET02012 | |
| 0.057 | 0.026 | 0.125 | Lysophosphatidic acid 3 receptor antagonist | 0.125 0.003 DBMET02012 0.063 0.02 DBMET02013 | DBMET02012 | |
| 0.051 | 0.02 | 0.051 | Glutamate (mGluR1a) antagonist | 0.039 0.031 DBMET02012 | ||
| 0.062 | 0.032 | 0.062 | Acetylcholine muscarinic agonist | |||
| 0.048 | 0.018 | 0.105 | GABA uptake inhibitor | 0.091 0.004 DBMET02012 0.105 0.004 DBMET02013 | DBMET02013 | |
| 0.036 | 0.007 | 0.048 | Nicotinic acid receptor 2 antagonist | 0.048 0.004 DBMET02012 0.027 0.018 DBMET02013 | DBMET02012 | |
| 0.115 | 0.086 | 0.116 | Cyclooxygenase 1 inhibitor | 0.116 0.084 DBMET02012 | DBMET02012 | |
| 0.044 | 0.015 | 0.057 | Integrin alpha2 antagonist | 0.057 0.008 DBMET02012 | DBMET02012 | |
| 0.161 | 0.133 | 0.17 | Antiamyloidogenic | 0.17 0.123 DBMET02012 | DBMET02012 | |
| 0.117 | 0.089 | 0.262 | Bone formation stimulant | 0.262 0.023 DBMET02012 0.261 0.023 DBMET02013 | DBMET02012 | |
| 0.035 | 0.007 | 0.035 | Inosine monophosphate dehydrogenase 1 inhibitor | |||
| 0.094 | 0.067 | 0.148 | Sphingomyelinase inhibitor | 0.148 0.025 DBMET02012 0.114 0.046 DBMET02013 | DBMET02012 | |
| 0.045 | 0.018 | 0.098 | Arginase inhibitor | 0.098 0.004 DBMET02012 0.055 0.012 DBMET02013 | DBMET02012 | |
| 0.051 | 0.024 | 0.051 | Nicotinic receptor alpha3 subunit antagonist | 0.039 0.037 DBMET02013 | ||
| 0.072 | 0.046 | 0.072 | Secretase beta inhibitor | |||
| 0.042 | 0.016 | 0.042 | Sirtuin 2 inhibitor | |||
| 0.065 | 0.039 | 0.069 | Calcium channel P-type blocker | 0.069 0.03 DBMET02012 | DBMET02012 | |
| 0.037 | 0.01 | 0.04 | Caspase 6 inhibitor | 0.04 0.007 DBMET02012 0.033 0.015 DBMET02013 | DBMET02012 | |
| 0.045 | 0.02 | 0.111 | Retinoid X receptor agonist | 0.111 0.004 DBMET02012 | DBMET02012 | |
| 0.045 | 0.02 | 0.115 | Membrane dipeptidase inhibitor | 0.115 0.003 DBMET02012 0.056 0.012 DBMET02013 | DBMET02012 | |
| 0.037 | 0.013 | 0.078 | Glutamate (mGluR3) agonist | 0.078 0.003 DBMET02012 0.042 0.009 DBMET02013 | DBMET02012 | |
| 0.063 | 0.038 | 0.063 | Phosphodiesterase 1B inhibitor | |||
| 0.05 | 0.026 | 0.05 | Acetylcholine M1 receptor agonist | |||
| 0.057 | 0.033 | 0.069 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.064 0.026 DBMET02012 0.069 0.022 DBMET02013 | DBMET02013 | |
| 0.051 | 0.027 | 0.06 | Dopamine beta hydroxylase inhibitor | 0.06 0.015 DBMET02012 | DBMET02012 | |
| 0.033 | 0.01 | 0.033 | Integrin alpha2beta1 antagonist | 0.032 0.01 DBMET02012 | ||
| 0.036 | 0.014 | 0.063 | Uridine phosphorylase inhibitor | 0.063 0.005 DBMET02012 0.051 0.008 DBMET02013 | DBMET02012 | |
| 0.032 | 0.009 | 0.066 | Lysophosphatidic acid receptor 1 agonist | 0.066 0.003 DBMET02012 0.039 0.006 DBMET02013 | DBMET02012 | |
| 0.031 | 0.009 | 0.049 | Vanilloid 2 agonist | 0.049 0.003 DBMET02012 0.028 0.013 DBMET02013 | DBMET02012 | |
| 0.039 | 0.016 | 0.039 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.064 | 0.042 | 0.21 | NMDA receptor agonist | 0.21 0.004 DBMET02012 0.067 0.039 DBMET02013 | DBMET02012 | |
| 0.076 | 0.055 | 0.083 | Estrogen receptor alpha antagonist | 0.083 0.045 DBMET02012 0.07 0.067 DBMET02013 | DBMET02012 | |
| 0.034 | 0.012 | 0.042 | Purinergic P2Y15 antagonist | 0.042 0.006 DBMET02012 0.034 0.012 DBMET02013 | DBMET02012 | |
| 0.083 | 0.061 | 0.114 | D-Ala-D-Ala ligase inhibitor | 0.114 0.017 DBMET02012 0.078 0.074 DBMET02013 | DBMET02012 | |
| 0.113 | 0.092 | 0.198 | NADPH oxidase inhibitor | 0.123 0.079 DBMET02012 0.198 0.035 DBMET02013 | DBMET02013 | |
| 0.041 | 0.02 | 0.041 | Delayed rectifier potassium channel blocker | |||
| 0.042 | 0.021 | 0.042 | Progesterone antagonist | |||
| 0.045 | 0.024 | 0.047 | Heme oxygenase inhibitor | 0.047 0.018 DBMET02012 | DBMET02012 | |
| 0.086 | 0.066 | 0.086 | Phosphodiesterase I inhibitor | |||
| 0.025 | 0.005 | 0.078 | Carbonic anhydrase X inhibitor | 0.078 0.002 DBMET02012 0.026 0.005 DBMET02013 | DBMET02012 | |
| 0.025 | 0.005 | 0.078 | Carbonic anhydrase VIII inhibitor | 0.078 0.002 DBMET02012 0.026 0.005 DBMET02013 | DBMET02012 | |
| 0.055 | 0.036 | 0.055 | Acetylcholine M2 receptor agonist | |||
| 0.215 | 0.197 | 0.23 | 15-Lipoxygenase inhibitor | 0.23 0.182 DBMET02012 | DBMET02012 | |
| 0.039 | 0.021 | 0.128 | Retinoid X alpha receptor agonist | 0.128 0.004 DBMET02012 | DBMET02012 | |
| 0.04 | 0.022 | 0.043 | Inosine monophosphate dehydrogenase inhibitor | 0.043 0.019 DBMET02012 | DBMET02012 | |
| 0.023 | 0.005 | 0.031 | Telomerase stimulant | 0.031 0.003 DBMET02012 0.019 0.008 DBMET02013 | DBMET02012 | |
| 0.054 | 0.036 | 0.054 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.089 | 0.072 | 0.089 | MAO A inhibitor | |||
| 0.084 | 0.068 | 0.084 | Bromodomain-containing protein 2 inhibitor | 0.084 0.068 DBMET02012 | ||
| 0.037 | 0.021 | 0.052 | Tryptophan 5 hydroxylase inhibitor | 0.052 0.005 DBMET02012 | DBMET02012 | |
| 0.038 | 0.023 | 0.074 | Nicotinic acid receptor agonist | 0.074 0.008 DBMET02012 | DBMET02012 | |
| 0.035 | 0.02 | 0.038 | Melatonin receptor 1A agonist | 0.038 0.016 DBMET02012 | DBMET02012 | |
| 0.044 | 0.029 | 0.123 | Glutamate (mGluR4) antagonist | 0.123 0.004 DBMET02012 0.041 0.035 DBMET02013 | DBMET02012 | |
| 0.02 | 0.005 | 0.048 | Lysophosphatidic acid receptor 3 agonist | 0.048 0.003 DBMET02012 0.027 0.004 DBMET02013 | DBMET02012 | |
| 0.049 | 0.034 | 0.068 | HCV NS3/NS4A protease inhibitor | 0.068 0.016 DBMET02012 0.045 0.043 DBMET02013 | DBMET02012 | |
| 0.026 | 0.011 | 0.128 | Glutamate (mGluR1a) agonist | 0.128 0.003 DBMET02012 0.051 0.005 DBMET02013 | DBMET02012 | |
| 0.056 | 0.041 | 0.056 | Fatty acid synthase inhibitor | 0.056 0.04 DBMET02012 | ||
| 0.093 | 0.079 | 0.093 | mTOR complex 1 inhibitor | |||
| 0.031 | 0.017 | 0.075 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.048 0.009 DBMET02012 0.075 0.005 DBMET02013 | DBMET02013 | |
| 0.026 | 0.012 | 0.071 | Prostaglandin F2 alpha agonist | 0.071 0.003 DBMET02012 0.038 0.006 DBMET02013 | DBMET02012 | |
| 0.057 | 0.043 | 0.057 | Aromatase inhibitor | |||
| 0.054 | 0.041 | 0.087 | Carbonic anhydrase VB inhibitor | 0.087 0.02 DBMET02012 | DBMET02012 | |
| 0.08 | 0.067 | 0.106 | Histamine N-methyltransferase inhibitor | 0.106 0.04 DBMET02012 | DBMET02012 | |
| 0.038 | 0.026 | 0.075 | Retinoid X receptor antagonist | 0.075 0.003 DBMET02012 0.039 0.025 DBMET02013 | DBMET02012 | |
| 0.073 | 0.061 | 0.155 | Macrophage migration inhibitory factor inhibitor | 0.155 0.014 DBMET02012 0.075 0.057 DBMET02013 | DBMET02012 | |
| 0.033 | 0.021 | 0.096 | ATP citrate lysase inhibitor | 0.096 0.004 DBMET02012 | DBMET02012 | |
| 0.056 | 0.044 | 0.104 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.104 0.015 DBMET02012 | DBMET02012 | |
| 0.037 | 0.025 | 0.151 | Glutamate (mGluR3) antagonist | 0.151 0.004 DBMET02012 0.036 0.026 DBMET02013 | DBMET02012 | |
| 0.091 | 0.08 | 0.18 | Falcipain 3 inhibitor | 0.14 0.042 DBMET02012 0.18 0.024 DBMET02013 | DBMET02013 | |
| 0.02 | 0.009 | 0.029 | Methylmalonyl-CoA mutase inhibitor | 0.029 0.003 DBMET02012 0.027 0.003 DBMET02013 | DBMET02012 | |
| 0.034 | 0.024 | 0.064 | Retinoid X alpha receptor antagonist | 0.064 0.003 DBMET02012 0.035 0.022 DBMET02013 | DBMET02012 | |
| 0.028 | 0.018 | 0.035 | Hedgehog signaling activator | 0.035 0.006 DBMET02012 0.028 0.018 DBMET02013 | DBMET02012 | |
| 0.02 | 0.01 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.006 DBMET02012 0.02 0.01 DBMET02013 | DBMET02012 | |
| 0.059 | 0.05 | 0.162 | Caspase 9 inhibitor | 0.162 0.005 DBMET02012 0.126 0.008 DBMET02013 | DBMET02012 | |
| 0.02 | 0.011 | 0.02 | Cyclin T1 inhibitor | |||
| 0.054 | 0.046 | 0.093 | Leukotriene C antagonist | 0.093 0.005 DBMET02012 0.055 0.043 DBMET02013 | DBMET02012 | |
| 0.033 | 0.025 | 0.093 | Free fatty acid receptor 1 antagonist | 0.093 0.003 DBMET02012 | DBMET02012 | |
| 0.09 | 0.082 | 0.211 | Mediator release inhibitor | 0.211 0.013 DBMET02012 | DBMET02012 | |
| 0.048 | 0.04 | 0.052 | Prolyl endopeptidase inhibitor | 0.052 0.034 DBMET02012 0.047 0.04 DBMET02013 | DBMET02012 | |
| 0.132 | 0.124 | 0.148 | Tumour necrosis factor antagonist | 0.148 0.103 DBMET02012 | DBMET02012 | |
| 0.085 | 0.077 | 0.117 | MAP kinase kinase 1 inhibitor | 0.117 0.038 DBMET02013 | DBMET02013 | |
| 0.091 | 0.083 | 0.217 | Monophenol monooxygenase inhibitor | 0.217 0.029 DBMET02012 | DBMET02012 | |
| 0.026 | 0.018 | 0.026 | Complement factor 1r inhibitor | |||
| 0.037 | 0.03 | 0.05 | Vanilloid 3 antagonist | 0.05 0.008 DBMET02012 | DBMET02012 | |
| 0.02 | 0.013 | 0.02 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.014 | 0.007 | 0.051 | Glutamate (mGluR6) agonist | 0.051 0.002 DBMET02012 0.014 0.006 DBMET02013 | DBMET02012 | |
| 0.048 | 0.042 | 0.048 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.021 | 0.014 | 0.035 | Neuraminidase (Influenza B) inhibitor | 0.035 0.004 DBMET02012 0.023 0.011 DBMET02013 | DBMET02012 | |
| 0.026 | 0.019 | 0.028 | Sodium/glucose cotransporter 2 inhibitor | 0.024 0.022 DBMET02012 0.028 0.015 DBMET02013 | DBMET02013 | |
| 0.016 | 0.01 | 0.019 | Purinergic P2Y1 agonist | 0.019 0.007 DBMET02012 0.015 0.011 DBMET02013 | DBMET02012 | |
| 0.021 | 0.014 | 0.051 | Retinoid X beta receptor antagonist | 0.051 0.002 DBMET02012 0.022 0.01 DBMET02013 | DBMET02012 | |
| 0.03 | 0.024 | 0.033 | Cholesterol ester transfer protein antagonist | 0.033 0.02 DBMET02012 | DBMET02012 | |
| 0.04 | 0.034 | 0.085 | Leukocyte elastase inhibitor | 0.085 0.012 DBMET02012 | DBMET02012 | |
| 0.016 | 0.01 | 0.043 | Thromboxane A2 agonist | 0.043 0.002 DBMET02012 0.027 0.004 DBMET02013 | DBMET02012 | |
| 0.117 | 0.112 | 0.168 | Acetylcholine M1 receptor antagonist | 0.168 0.06 DBMET02012 | DBMET02012 | |
| 0.025 | 0.02 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.024 0.021 DBMET02012 0.026 0.018 DBMET02013 | DBMET02013 | |
| 0.091 | 0.086 | 0.11 | Beta glucuronidase inhibitor | 0.11 0.056 DBMET02013 | DBMET02013 | |
| 0.083 | 0.079 | 0.083 | Protein kinase C zeta inhibitor | |||
| 0.027 | 0.022 | 0.027 | Nicotinic alpha4beta2 receptor agonist | 0.026 0.024 DBMET02013 | ||
| 0.041 | 0.037 | 0.12 | Glutamate (mGluR group III) antagonist | 0.12 0.004 DBMET02012 | DBMET02012 | |
| 0.034 | 0.03 | 0.034 | ATM kinase inhibitor | |||
| 0.019 | 0.015 | 0.032 | Caspase 8 inhibitor | 0.032 0.004 DBMET02012 0.021 0.011 DBMET02013 | DBMET02012 | |
| 0.022 | 0.018 | 0.033 | Isoleucine-tRNA ligase inhibitor | 0.033 0.004 DBMET02012 0.028 0.007 DBMET02013 | DBMET02012 | |
| 0.079 | 0.075 | 0.102 | Vanilloid agonist | 0.102 0.03 DBMET02012 | DBMET02012 | |
| 0.085 | 0.081 | 0.13 | Xanthine oxidase inhibitor | 0.13 0.043 DBMET02012 | DBMET02012 | |
| 0.032 | 0.029 | 0.09 | Phosphoglycerate kinase inhibitor | 0.09 0.008 DBMET02012 0.061 0.011 DBMET02013 | DBMET02012 | |
| 0.013 | 0.01 | 0.015 | Antibiotic Macrolide-like | 0.015 0.009 DBMET02013 | DBMET02013 | |
| 0.033 | 0.03 | 0.043 | Ceramide glucosyltransferase inhibitor | 0.043 0.013 DBMET02012 0.036 0.023 DBMET02013 | DBMET02012 | |
| 0.081 | 0.079 | 0.302 | Alcohol dehydrogenase inhibitor | 0.302 0.005 DBMET02012 0.268 0.006 DBMET02013 | DBMET02012 | |
| 0.024 | 0.022 | 0.026 | Acid ceramidase inhibitor | 0.026 0.018 DBMET02012 | DBMET02012 | |
| 0.025 | 0.024 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.014 DBMET02012 0.031 0.01 DBMET02013 | DBMET02013 | |
| 0.032 | 0.032 | 0.122 | 5-Alpha-reductase inhibitor | 0.122 0.008 DBMET02012 | DBMET02012 | |
| 0.065 | 0.064 | 0.065 | Acetylcholine M4 receptor antagonist | |||
| 0.026 | 0.026 | 0.047 | Estrogen-related receptor gamma antagonist | 0.038 0.006 DBMET02012 0.047 0.004 DBMET02013 | DBMET02013 | |
| 0.022 | 0.023 | 0.109 | Glutamate (mGluR1) agonist | 0.109 0.004 DBMET02012 0.031 0.009 DBMET02013 | DBMET02012 | |
| 0.06 | 0.06 | 0.095 | Carbonic anhydrase VA inhibitor | 0.095 0.027 DBMET02012 | DBMET02012 | |
| 0.039 | 0.039 | 0.05 | Nerve growth factor antagonist | 0.05 0.018 DBMET02012 | DBMET02012 | |
| 0.023 | 0.024 | 0.082 | Lysine carboxypeptidase inhibitor | 0.082 0.004 DBMET02012 0.034 0.013 DBMET02013 | DBMET02012 | |
| 0.006 | 0.006 | 0.012 | Integrin alpha5beta6 antagonist | 0.012 0.003 DBMET02012 | DBMET02012 | |
| 0.057 | 0.058 | 0.094 | Carbonic anhydrase V inhibitor | 0.094 0.029 DBMET02012 | DBMET02012 | |
| 0.052 | 0.053 | 0.064 | Immunoglobulin Fc receptor antagonist | 0.064 0.017 DBMET02012 0.054 0.042 DBMET02013 | DBMET02012 | |
| 0.069 | 0.07 | 0.086 | Acetylcholine nicotinic antagonist | 0.086 0.048 DBMET02012 | DBMET02012 | |
| 0.049 | 0.05 | 0.076 | Sphingosine kinase 2 inhibitor | 0.068 0.023 DBMET02012 0.076 0.018 DBMET02013 | DBMET02013 | |
| 0.049 | 0.052 | 0.056 | Epithelial sodium channel blocker | 0.056 0.035 DBMET02012 0.055 0.037 DBMET02013 | DBMET02012 | |
| 0.023 | 0.026 | 0.024 | Complement factor 1s inhibitor | 0.024 0.022 DBMET02012 | DBMET02012 | |
| 0.01 | 0.014 | 0.028 | Carbonic anhydrase XI inhibitor | 0.028 0.003 DBMET02012 | DBMET02012 | |
| 0.057 | 0.061 | 0.18 | Leukotriene synthesis inhibitor | 0.18 0.006 DBMET02012 0.109 0.021 DBMET02013 | DBMET02012 | |
| 0.006 | 0.01 | 0.011 | Integrin alphaVbeta5 antagonist | 0.011 0.006 DBMET02012 | DBMET02012 | |
| 0.038 | 0.042 | 0.088 | Adenosine deaminase inhibitor | 0.079 0.009 DBMET02012 0.088 0.007 DBMET02013 | DBMET02013 | |
| 0.114 | 0.118 | 0.173 | Farnesoid X receptor antagonist | 0.173 0.033 DBMET02012 | DBMET02012 | |
| 0.043 | 0.048 | 0.065 | Bombesin 2 receptor antagonist | 0.065 0.021 DBMET02012 | DBMET02012 | |
| 0.038 | 0.042 | 0.078 | Geranyltranstransferase inhibitor | 0.078 0.005 DBMET02012 0.07 0.008 DBMET02013 | DBMET02012 | |
| 0.033 | 0.038 | 0.155 | Toll-Like receptor 2 agonist | 0.155 0.01 DBMET02012 0.046 0.025 DBMET02013 | DBMET02012 | |
| 0.051 | 0.055 | 0.113 | Sphingosine 1-phosphate receptor 3 antagonist | 0.113 0.005 DBMET02012 0.056 0.044 DBMET02013 | DBMET02012 | |
| 0.032 | 0.037 | 0.044 | Glutamate (mGluR group II) antagonist | 0.044 0.021 DBMET02012 | DBMET02012 | |
| 0.026 | 0.031 | 0.045 | Epoxide hydrolase 1 inhibitor | 0.045 0.008 DBMET02012 | DBMET02012 | |
| 0.035 | 0.041 | 0.054 | Thymidine kinase inhibitor | 0.053 0.017 DBMET02012 0.054 0.016 DBMET02013 | DBMET02013 | |
| 0.062 | 0.068 | 0.109 | MDM2 inhibitor | 0.109 0.005 DBMET02012 0.072 0.033 DBMET02013 | DBMET02012 | |
| 0.047 | 0.054 | 0.07 | Heparanase inhibitor | 0.07 0.011 DBMET02012 0.053 0.037 DBMET02013 | DBMET02012 | |
| 0.01 | 0.017 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.019 0.004 DBMET02012 | DBMET02012 | |
| 0.09 | 0.097 | 0.261 | DNA polymerase I inhibitor | 0.261 0.015 DBMET02012 | DBMET02012 | |
| 0.035 | 0.042 | 0.068 | Leukotriene C4 antagonist | 0.068 0.004 DBMET02012 | DBMET02012 | |
| 0.036 | 0.043 | 0.041 | Histamine H2 receptor agonist | 0.041 0.033 DBMET02012 | DBMET02012 | |
| 0.007 | 0.015 | 0.042 | Thromboxane agonist | 0.042 0.002 DBMET02012 0.014 0.005 DBMET02013 | DBMET02012 | |
| 0.143 | 0.151 | 0.184 | Histone acetyltransferase inhibitor | 0.184 0.094 DBMET02012 | DBMET02012 | |
| 0.033 | 0.041 | 0.06 | Oxytocin agonist | 0.06 0.017 DBMET02012 0.049 0.025 DBMET02013 | DBMET02012 | |
| 0.037 | 0.045 | 0.079 | GABA B receptor antagonist | 0.079 0.006 DBMET02012 | DBMET02012 | |
| 0.014 | 0.023 | 0.1 | 5-Alpha-reductase 2 inhibitor | 0.1 0.005 DBMET02012 | DBMET02012 | |
| 0.028 | 0.037 | 0.042 | RNA-directed RNA polymerase inhibitor | 0.042 0.017 DBMET02012 | DBMET02012 | |
| 0.008 | 0.018 | 0.013 | Egl nine homolog 3 inhibitor | 0.013 0.007 DBMET02012 | DBMET02012 | |
| 0.075 | 0.085 | 0.092 | CC chemokine 5 receptor agonist | 0.092 0.032 DBMET02012 | DBMET02012 | |
| 0.103 | 0.113 | 0.194 | Sphingosine 1-phosphate receptor 4 antagonist | 0.194 0.01 DBMET02012 0.128 0.059 DBMET02013 | DBMET02012 | |
| 0.019 | 0.03 | 0.026 | ICAM 1 antagonist | 0.026 0.011 DBMET02012 | DBMET02012 | |
| 0.013 | 0.024 | 0.027 | Nicotinic acid receptor 1 antagonist | 0.027 0.005 DBMET02012 | DBMET02012 | |
| 0.022 | 0.033 | 0.025 | Thymidine phosphorylase inhibitor | 0.025 0.02 DBMET02012 0.024 0.023 DBMET02013 | DBMET02012 | |
| 0.073 | 0.085 | 0.094 | Thioredoxin reductase inhibitor | 0.094 0.035 DBMET02013 | DBMET02013 | |
| 0.024 | 0.037 | 0.055 | Calcitonin receptor agonist | 0.055 0.016 DBMET02012 0.034 0.023 DBMET02013 | DBMET02012 | |
| 0.022 | 0.034 | 0.036 | LFA antagonist | 0.036 0.01 DBMET02012 | DBMET02012 | |
| 0.045 | 0.057 | 0.098 | Leukotriene B4 antagonist | 0.098 0.011 DBMET02012 | DBMET02012 | |
| 0.013 | 0.026 | 0.024 | Vitamin D receptor agonist | 0.024 0.005 DBMET02012 0.016 0.012 DBMET02013 | DBMET02012 | |
| 0.017 | 0.03 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.009 DBMET02012 0.023 0.009 DBMET02013 | DBMET02012 | |
| 0.047 | 0.06 | 0.16 | Carbonic anhydrase stimulant | 0.16 0.01 DBMET02012 | DBMET02012 | |
| 0.008 | 0.021 | 0.013 | Integrin beta2 antagonist | 0.013 0.008 DBMET02012 | DBMET02012 | |
| 0.029 | 0.043 | 0.035 | Alpha 1d adrenoreceptor agonist | 0.035 0.032 DBMET02012 | DBMET02012 | |
| 0.03 | 0.045 | 0.034 | Adenosine uptake inhibitor | 0.034 0.028 DBMET02012 | DBMET02012 | |
| 0.037 | 0.051 | 0.041 | Histamine H1 receptor agonist | 0.041 0.038 DBMET02012 | DBMET02012 | |
| 0.083 | 0.098 | 0.107 | Phosphodiesterase 6D inhibitor | 0.107 0.04 DBMET02012 | DBMET02012 | |
| 0.007 | 0.022 | 0.082 | Prostaglandin EP4 agonist | 0.082 0.004 DBMET02012 | DBMET02012 | |
| 0.012 | 0.027 | 0.015 | Nicotinic alpha4 receptor agonist | 0.015 0.014 DBMET02013 | DBMET02013 | |
| 0.026 | 0.042 | 0.044 | Carnitine palmitoyltransferase 1 inhibitor | 0.044 0.012 DBMET02012 | DBMET02012 | |
| 0.008 | 0.023 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 DBMET02013 | DBMET02013 | |
| 0.034 | 0.05 | 0.136 | Antimetabolite | 0.136 0.013 DBMET02012 0.058 0.027 DBMET02013 | DBMET02012 | |
| 0.022 | 0.038 | 0.04 | HCV NS5B polymerase inhibitor | 0.04 0.014 DBMET02012 | DBMET02012 | |
| 0.009 | 0.025 | 0.081 | 5-Alpha-reductase 1 inhibitor | 0.081 0.005 DBMET02012 | DBMET02012 | |
| 0.015 | 0.031 | 0.044 | Prostaglandin H2 antagonist | 0.044 0.004 DBMET02012 | DBMET02012 | |
| 0.033 | 0.05 | 0.086 | Glutamate (mGluR group III) agonist | 0.086 0.012 DBMET02012 | DBMET02012 | |
| 0.01 | 0.027 | 0.036 | Aminopeptidase A inhibitor | 0.036 0.005 DBMET02012 | DBMET02012 | |
| 0.026 | 0.043 | 0.046 | Carnitine palmitoyltransferase inhibitor | 0.046 0.011 DBMET02012 | DBMET02012 | |
| 0.026 | 0.044 | 0.052 | Farnesoid X receptor agonist | 0.052 0.014 DBMET02012 | DBMET02012 | |
| 0.03 | 0.049 | 0.043 | MAP3K5 inhibitor | 0.043 0.021 DBMET02012 | DBMET02012 | |
| 0.025 | 0.044 | 0.03 | Elastase 2B inhibitor | 0.03 0.023 DBMET02012 | DBMET02012 | |
| 0.025 | 0.044 | 0.03 | Elastase 3A inhibitor | 0.03 0.023 DBMET02012 | DBMET02012 | |
| 0.025 | 0.044 | 0.03 | Elastase 3B inhibitor | 0.03 0.023 DBMET02012 | DBMET02012 | |
| 0.013 | 0.032 | 0.021 | CXC chemokine 5 receptor antagonist | 0.021 0.007 DBMET02012 | DBMET02012 | |
| 0.026 | 0.045 | 0.049 | Carboxypeptidase B inhibitor | 0.049 0.007 DBMET02012 | DBMET02012 | |
| 0.05 | 0.07 | 0.108 | Lipocortins synthesis agonist | 0.108 0.004 DBMET02012 0.055 0.048 DBMET02013 | DBMET02012 | |
| 0.068 | 0.087 | 0.126 | Inducible nitric-oxide synthase inhibitor | 0.126 0.022 DBMET02012 | DBMET02012 | |
| 0.055 | 0.075 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.033 DBMET02012 | DBMET02012 | |
| 0.167 | 0.188 | 0.237 | Neuropeptide Y2 antagonist | 0.237 0.07 DBMET02012 | DBMET02012 | |
| 0.021 | 0.041 | 0.105 | Prostaglandin agonist | 0.105 0.005 DBMET02012 | DBMET02012 | |
| 0.056 | 0.077 | 0.174 | Cathepsin G inhibitor | 0.174 0.018 DBMET02012 0.085 0.04 DBMET02013 | DBMET02012 | |
| 0.008 | 0.029 | 0.018 | Integrin alphaVbeta6 antagonist | 0.018 0.007 DBMET02012 | DBMET02012 | |
| 0.034 | 0.055 | 0.086 | AICAR transformylase inhibitor | 0.086 0.006 DBMET02012 0.059 0.015 DBMET02013 | DBMET02012 | |
| 0.021 | 0.043 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.018 DBMET02012 | DBMET02012 | |
| 0.008 | 0.031 | 0.043 | G-protein-coupled receptor 120 agonist | 0.043 0.004 DBMET02012 0.015 0.014 DBMET02013 | DBMET02012 | |
| 0.005 | 0.028 | 0.011 | Angiotensin AT2 receptor agonist | 0.011 0.006 DBMET02012 | DBMET02012 | |
| 0.015 | 0.039 | 0.075 | Kynurenine 3 monooxygenase inhibitor | 0.075 0.004 DBMET02012 | DBMET02012 | |
| 0.021 | 0.045 | 0.112 | Lysophosphatidic acid 2 receptor antagonist | 0.112 0.004 DBMET02012 0.038 0.014 DBMET02013 | DBMET02012 | |
| 0.027 | 0.052 | 0.064 | Dihydropteroate synthase inhibitor | 0.064 0.01 DBMET02012 | DBMET02012 | |
| 0.016 | 0.04 | 0.027 | Retinoic acid receptor agonist | 0.027 0.012 DBMET02012 | DBMET02012 | |
| 0.164 | 0.189 | 0.218 | 12-Lipoxygenase inhibitor | 0.218 0.132 DBMET02012 | DBMET02012 | |
| 0.013 | 0.038 | 0.033 | Corticosteroid-like | 0.033 0.005 DBMET02012 | DBMET02012 | |
| 0.034 | 0.059 | 0.056 | Metalloproteinase-3 inhibitor | 0.056 0.027 DBMET02012 | DBMET02012 | |
| 0.027 | 0.053 | 0.037 | DNA gyrase subunit B inhibitor | 0.037 0.028 DBMET02012 | DBMET02012 | |
| 0.011 | 0.037 | 0.066 | Prostaglandin EP2 agonist | 0.066 0.004 DBMET02012 | DBMET02012 | |
| 0.028 | 0.055 | 0.041 | Calcium-independent phospholipase A2 inhibitor | 0.041 0.009 DBMET02012 | DBMET02012 | |
| 0.047 | 0.073 | 0.1 | Sphingosine kinase inhibitor | 0.074 0.021 DBMET02012 0.1 0.008 DBMET02013 | DBMET02013 | |
| 0.032 | 0.059 | 0.063 | Dihydroorotase inhibitor | 0.063 0.014 DBMET02012 | DBMET02012 | |
| 0.145 | 0.172 | 0.318 | Antioxidant | 0.318 0.055 DBMET02012 0.224 0.099 DBMET02013 | DBMET02012 | |
| 0.073 | 0.1 | 0.115 | Hematopoietic | 0.115 0.024 DBMET02012 | DBMET02012 | |
| 0.014 | 0.042 | 0.044 | Lysophosphatidic acid 1 receptor antagonist | 0.044 0.004 DBMET02012 | DBMET02012 | |
| 0.012 | 0.04 | 0.063 | Prostaglandin E2 agonist | 0.063 0.005 DBMET02012 | DBMET02012 | |
| 0.034 | 0.062 | 0.094 | Carbonic anhydrase XIV inhibitor | 0.094 0.012 DBMET02012 | DBMET02012 | |
| 0.015 | 0.044 | 0.02 | Toll-Like receptor 8 agonist | 0.02 0.015 DBMET02012 0.02 0.016 DBMET02013 | DBMET02013 | |
| 0.019 | 0.048 | 0.052 | Peptide deformylase inhibitor | 0.052 0.009 DBMET02012 | DBMET02012 | |
| 0.045 | 0.074 | 0.077 | Neutrophil collagenase inhibitor | 0.077 0.034 DBMET02012 | DBMET02012 | |
| 0.04 | 0.07 | 0.085 | CD45 antagonist | 0.085 0.011 DBMET02012 | DBMET02012 | |
| 0.031 | 0.061 | 0.081 | Thymidylate synthase inhibitor | 0.081 0.007 DBMET02012 0.071 0.011 DBMET02013 | DBMET02012 | |
| 0.015 | 0.047 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.032 0.007 DBMET02012 | DBMET02012 | |
| 0.064 | 0.096 | 0.078 | Myeloperoxidase inhibitor | 0.078 0.071 DBMET02012 | DBMET02012 | |
| 0.067 | 0.099 | 0.16 | 5-Lipoxygenase inhibitor | 0.16 0.034 DBMET02012 | DBMET02012 | |
| 0.042 | 0.075 | 0.105 | Glucosylceramidase inhibitor | 0.06 0.031 DBMET02012 0.105 0.007 DBMET02013 | DBMET02013 | |
| 0.018 | 0.051 | 0.033 | Calcium-sensing receptor agonist | 0.033 0.011 DBMET02012 | DBMET02012 | |
| 0.012 | 0.046 | 0.023 | Estrogen-related receptor gamma agonist | 0.023 0.007 DBMET02012 0.022 0.008 DBMET02013 | DBMET02012 | |
| 0.082 | 0.116 | 0.118 | Acetylcholine muscarinic antagonist | 0.118 0.069 DBMET02012 | DBMET02012 | |
| 0.014 | 0.05 | 0.02 | Protease (Human cytomegalovirus) inhibitor | 0.02 0.019 DBMET02012 | DBMET02012 | |
| 0.004 | 0.04 | 0.013 | Carboxypeptidase B2 inhibitor | 0.013 0.006 DBMET02012 | DBMET02012 | |
| 0.097 | 0.134 | 0.117 | Cytidine deaminase inhibitor | 0.117 0.103 DBMET02012 | DBMET02012 | |
| 0.017 | 0.054 | 0.056 | Thyroid hormone agonist | 0.056 0.004 DBMET02012 | DBMET02012 | |
| 0.03 | 0.067 | 0.05 | Sphingosine kinase 1 inhibitor | 0.047 0.019 DBMET02012 0.05 0.016 DBMET02013 | DBMET02013 | |
| 0.028 | 0.066 | 0.095 | Thromboxane A2 antagonist | 0.095 0.009 DBMET02012 | DBMET02012 | |
| 0.037 | 0.075 | 0.052 | Elastase inhibitor | 0.052 0.038 DBMET02012 | DBMET02012 | |
| 0.038 | 0.077 | 0.063 | Matrix metalloproteinase (membrane-type) inhibitor | 0.063 0.03 DBMET02012 | DBMET02012 | |
| 0.052 | 0.092 | 0.078 | Epoxide hydrolase inhibitor | 0.078 0.044 DBMET02012 | DBMET02012 | |
| 0.043 | 0.084 | 0.145 | Leukotriene antagonist | 0.145 0.011 DBMET02012 | DBMET02012 | |
| 0.03 | 0.073 | 0.105 | Thromboxane antagonist | 0.105 0.009 DBMET02012 | DBMET02012 | |
| 0.019 | 0.062 | 0.051 | G protein-coupled receptor agonist | 0.051 0.017 DBMET02012 | DBMET02012 | |
| 0.006 | 0.049 | 0.016 | Egl nine homolog 1 inhibitor | 0.016 0.008 DBMET02012 | DBMET02012 | |
| 0.003 | 0.047 | 0.015 | Thyroid hormone beta agonist | 0.015 0.004 DBMET02012 | DBMET02012 | |
| 0.033 | 0.078 | 0.086 | Diacylglycerol O-acyltransferase inhibitor | 0.086 0.012 DBMET02012 | DBMET02012 | |
| 0.04 | 0.085 | 0.066 | Collagenase 3 inhibitor | 0.066 0.035 DBMET02012 | DBMET02012 | |
| 0.024 | 0.069 | 0.035 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.035 0.03 DBMET02013 | DBMET02013 | |
| 0.056 | 0.102 | 0.105 | Peroxisome proliferator-activated receptor gamma antagonist | 0.105 0.013 DBMET02012 | DBMET02012 | |
| 0.026 | 0.072 | 0.108 | Ribonucleoside-diphosphate reductase inhibitor | 0.108 0.018 DBMET02012 0.061 0.033 DBMET02013 | DBMET02012 | |
| 0.054 | 0.1 | 0.094 | Metalloproteinase-2 inhibitor | 0.094 0.041 DBMET02012 | DBMET02012 | |
| 0.026 | 0.073 | 0.107 | Ribonucleotide reductase inhibitor | 0.107 0.019 DBMET02012 0.063 0.035 DBMET02013 | DBMET02012 | |
| 0.027 | 0.074 | 0.12 | AMPA 4 receptor antagonist | 0.12 0.004 DBMET02012 | DBMET02012 | |
| 0.054 | 0.102 | 0.075 | Metalloproteinase-9 inhibitor | 0.075 0.048 DBMET02012 | DBMET02012 | |
| 0.028 | 0.076 | 0.068 | Fructose-1,6-bisphosphatase inhibitor | 0.068 0.013 DBMET02012 | DBMET02012 | |
| 0.033 | 0.081 | 0.059 | Cathepsin L inhibitor | 0.059 0.04 DBMET02013 | DBMET02013 | |
| 0.093 | 0.141 | 0.143 | Antibacterial (Helicobacter pylori) | 0.143 0.053 DBMET02012 | DBMET02012 | |
| 0.019 | 0.068 | 0.035 | Cathepsin L1 inhibitor | 0.035 0.032 DBMET02013 | DBMET02013 | |
| 0.005 | 0.055 | 0.061 | Peroxisome proliferator-activated receptor alpha antagonist | 0.061 0.007 DBMET02012 | DBMET02012 | |
| 0.11 | 0.162 | 0.274 | DNA methyltransferase I inhibitor | 0.274 0.037 DBMET02012 | DBMET02012 | |
| 0.038 | 0.09 | 0.097 | Thromboxane synthase inhibitor | 0.097 0.007 DBMET02012 0.052 0.043 DBMET02013 | DBMET02012 | |
| 0.024 | 0.077 | 0.078 | Sphingosine 1-phosphate receptor 1 agonist | 0.078 0.006 DBMET02012 0.04 0.033 DBMET02013 | DBMET02012 | |
| 0.006 | 0.061 | 0.064 | Prostacyclin agonist | 0.064 0.004 DBMET02012 | DBMET02012 | |
| 0.045 | 0.099 | 0.073 | Corticotropin releasing factor 2 receptor antagonist | 0.073 0.024 DBMET02012 | DBMET02012 | |
| 0.01 | 0.065 | 0.028 | NMDA receptor glycine site antagonist | 0.028 0.014 DBMET02012 | DBMET02012 | |
| 0.023 | 0.078 | 0.049 | Glutamate (mGluR4) agonist | 0.049 0.011 DBMET02012 | DBMET02012 | |
| 0.032 | 0.088 | 0.065 | Beta 1 adrenoreceptor antagonist | 0.065 0.031 DBMET02012 0.061 0.034 DBMET02013 | DBMET02012 | |
| 0.014 | 0.071 | 0.082 | Peroxisome proliferator-activated receptor delta agonist | 0.082 0.007 DBMET02012 | DBMET02012 | |
| 0.005 | 0.063 | 0.042 | Ileal bile acid transport inhibitor | 0.042 0.004 DBMET02012 | DBMET02012 | |
| 0.012 | 0.069 | 0.026 | CXC chemokine 2 receptor antagonist | 0.026 0.019 DBMET02012 | DBMET02012 | |
| 0.077 | 0.135 | 0.113 | Cholinergic antagonist | 0.113 0.08 DBMET02012 | DBMET02012 | |
| 0.076 | 0.135 | 0.107 | Acetylcholine antagonist | 0.107 0.083 DBMET02012 | DBMET02012 | |
| 0.068 | 0.128 | 0.112 | Nitric-oxide synthase inhibitor | 0.112 0.044 DBMET02012 | DBMET02012 | |
| 0.042 | 0.101 | 0.079 | Beta adrenoreceptor antagonist | 0.079 0.027 DBMET02012 0.061 0.053 DBMET02013 | DBMET02012 | |
| 0.037 | 0.096 | 0.072 | Matrix metalloproteinase inhibitor | 0.072 0.042 DBMET02012 | DBMET02012 | |
| 0.014 | 0.073 | 0.029 | Retinoic acid gamma receptor agonist | 0.029 0.007 DBMET02012 | DBMET02012 | |
| 0.016 | 0.076 | 0.052 | Methionyl aminopeptidase 1 inhibitor | 0.052 0.005 DBMET02012 | DBMET02012 | |
| 0.011 | 0.073 | 0.021 | Geranylgeranyltransferase inhibitor | 0.021 0.018 DBMET02012 | DBMET02012 | |
| 0.019 | 0.084 | 0.065 | Angiotensin II receptor antagonist | 0.065 0.004 DBMET02012 | DBMET02012 | |
| 0.004 | 0.069 | 0.027 | Angiotensin AT1B receptor antagonist | 0.027 0.004 DBMET02012 | DBMET02012 | |
| 0.021 | 0.087 | 0.089 | Glycine transporter 2 inhibitor | 0.089 0.015 DBMET02012 | DBMET02012 | |
| 0.024 | 0.09 | 0.087 | Sphingosine 1-phosphate receptor agonist | 0.087 0.007 DBMET02012 | DBMET02012 | |
| 0.021 | 0.088 | 0.065 | Angiotensin AT1 receptor antagonist | 0.065 0.004 DBMET02012 | DBMET02012 | |
| 0.02 | 0.087 | 0.107 | Peroxisome proliferator-activated receptor alpha agonist | 0.107 0.011 DBMET02012 | DBMET02012 | |
| 0.021 | 0.088 | 0.062 | Phosphorylase inhibitor | 0.052 0.029 DBMET02012 0.062 0.024 DBMET02013 | DBMET02013 | |
| 0.013 | 0.081 | 0.111 | Kainate receptor 2 antagonist | 0.111 0.004 DBMET02012 | DBMET02012 | |
| 0.025 | 0.093 | 0.091 | Xanthine dehydrogenase inhibitor | 0.065 0.034 DBMET02012 0.091 0.019 DBMET02013 | DBMET02013 | |
| 0.102 | 0.171 | 0.124 | Neuropeptide Y1 antagonist | 0.123 0.115 DBMET02012 0.124 0.114 DBMET02013 | DBMET02013 | |
| 0.04 | 0.109 | 0.056 | Cathepsin E inhibitor | 0.056 0.046 DBMET02012 | DBMET02012 | |
| 0.034 | 0.104 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.036 DBMET02012 | DBMET02012 | |
| 0.015 | 0.086 | 0.05 | Carbonic anhydrase IV inhibitor | 0.05 0.025 DBMET02012 | DBMET02012 | |
| 0.004 | 0.077 | 0.068 | Kainate receptor 1 antagonist | 0.068 0.004 DBMET02012 | DBMET02012 | |
| 0.011 | 0.084 | 0.058 | Prostaglandin EP4 antagonist | 0.058 0.007 DBMET02012 | DBMET02012 | |
| 0.077 | 0.151 | 0.107 | Electron transport complex I inhibitor | 0.107 0.067 DBMET02012 | DBMET02012 | |
| 0.106 | 0.18 | 0.255 | DNA methylase inhibitor | 0.255 0.045 DBMET02012 | DBMET02012 | |
| 0.018 | 0.093 | 0.087 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.087 0.004 DBMET02012 | DBMET02012 | |
| 0.017 | 0.092 | 0.087 | Urate transporter 1 inhibitor | 0.087 0.007 DBMET02012 | DBMET02012 | |
| 0.056 | 0.133 | 0.108 | Protease inhibitor | 0.084 0.081 DBMET02012 0.108 0.058 DBMET02013 | DBMET02013 | |
| 0.011 | 0.089 | 0.054 | Liver X receptor beta antagonist | 0.054 0.007 DBMET02012 | DBMET02012 | |
| 0.045 | 0.123 | 0.072 | Beta 3 adrenoreceptor antagonist | 0.072 0.03 DBMET02012 0.061 0.053 DBMET02013 | DBMET02012 | |
| 0.075 | 0.155 | 0.132 | Nav1.6 sodium channel blocker | 0.132 0.078 DBMET02012 | DBMET02012 | |
| 0.021 | 0.102 | 0.057 | Retinoic acid alpha receptor agonist | 0.057 0.01 DBMET02012 0.042 0.023 DBMET02013 | DBMET02012 | |
| 0.034 | 0.115 | 0.082 | Lipase inhibitor | 0.082 0.041 DBMET02013 | DBMET02013 | |
| 0.001 | 0.084 | 0.012 | Mannitol 2-dehydrogenase inhibitor | 0.012 0.004 DBMET02013 | DBMET02013 | |
| 0.029 | 0.111 | 0.054 | Benzodiazepine antagonist | 0.054 0.02 DBMET02012 | DBMET02012 | |
| 0.01 | 0.095 | 0.028 | Retinoic acid beta receptor agonist | 0.028 0.006 DBMET02012 0.019 0.017 DBMET02013 | DBMET02012 | |
| 0.074 | 0.159 | 0.122 | M17 leucyl aminopeptidase inhibitor | 0.122 0.076 DBMET02012 | DBMET02012 | |
| 0.087 | 0.174 | 0.374 | Angiogenesis stimulant | 0.374 0.027 DBMET02012 0.264 0.064 DBMET02013 | DBMET02012 | |
| 0.025 | 0.113 | 0.057 | Beta 2 adrenoreceptor antagonist | 0.057 0.027 DBMET02012 0.045 0.044 DBMET02013 | DBMET02012 | |
| 0.113 | 0.202 | 0.278 | Free radical scavenger | 0.278 0.058 DBMET02012 | DBMET02012 | |
| 0.019 | 0.111 | 0.044 | Oleamide hydrolase inhibitor | 0.044 0.032 DBMET02013 | DBMET02013 | |
| 0.015 | 0.107 | 0.12 | Purinergic P2Y antagonist | 0.12 0.007 DBMET02012 | DBMET02012 | |
| 0.031 | 0.124 | 0.078 | Cyclin D1 inhibitor | 0.078 0.02 DBMET02013 | DBMET02013 | |
| 0.021 | 0.114 | 0.101 | NMDA receptor subunit 3B antagonist | 0.101 0.01 DBMET02012 | DBMET02012 | |
| 0.051 | 0.144 | 0.084 | Chymotrypsin inhibitor | 0.076 0.06 DBMET02012 0.084 0.049 DBMET02013 | DBMET02013 | |
| 0.013 | 0.107 | 0.037 | Liver X receptor beta agonist | 0.037 0.018 DBMET02012 | DBMET02012 | |
| 0.013 | 0.106 | 0.104 | Kainate receptor antagonist | 0.104 0.007 DBMET02012 | DBMET02012 | |
| 0.05 | 0.144 | 0.102 | Urease inhibitor | 0.102 0.065 DBMET02012 | DBMET02012 | |
| 0.138 | 0.233 | 0.299 | Peptidyltransferase inhibitor | 0.299 0.025 DBMET02012 0.288 0.029 DBMET02013 | DBMET02012 | |
| 0.044 | 0.14 | 0.123 | Potassium channel (Ca-activated) activator | 0.123 0.039 DBMET02012 | DBMET02012 | |
| 0.009 | 0.106 | 0.063 | AMPA 3 receptor antagonist | 0.063 0.005 DBMET02012 | DBMET02012 | |
| 0.06 | 0.157 | 0.124 | GABA receptor agonist | 0.124 0.053 DBMET02012 | DBMET02012 | |
| 0.015 | 0.112 | 0.089 | NMDA receptor subunit 3A antagonist | 0.089 0.01 DBMET02012 | DBMET02012 | |
| 0.077 | 0.175 | 0.161 | Interleukin 8 antagonist | 0.161 0.028 DBMET02012 | DBMET02012 | |
| 0.022 | 0.12 | 0.056 | Dihydrofolate reductase inhibitor | 0.056 0.013 DBMET02012 | DBMET02012 | |
| 0.007 | 0.107 | 0.07 | Retinoid X beta receptor agonist | 0.07 0.004 DBMET02012 | DBMET02012 | |
| 0.09 | 0.19 | 0.284 | Pyruvate kinase inhibitor | 0.284 0.052 DBMET02012 | DBMET02012 | |
| 0.074 | 0.175 | 0.108 | Nav1.2 sodium channel blocker | 0.108 0.099 DBMET02012 | DBMET02012 | |
| 0.034 | 0.136 | 0.087 | Amidase inhibitor | 0.087 0.032 DBMET02012 | DBMET02012 | |
| 0.022 | 0.125 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.06 0.013 DBMET02012 0.042 0.038 DBMET02013 | DBMET02012 | |
| 0.034 | 0.139 | 0.109 | Neuraminidase (influenza) inhibitor | 0.109 0.014 DBMET02012 0.073 0.031 DBMET02013 | DBMET02012 | |
| 0.031 | 0.137 | 0.061 | Botulinum neurotoxin type A inhibitor | 0.061 0.037 DBMET02012 | DBMET02012 | |
| 0.008 | 0.117 | 0.077 | Retinoid X gamma receptor agonist | 0.077 0.004 DBMET02012 | DBMET02012 | |
| 0.019 | 0.13 | 0.053 | Liver X receptor alpha agonist | 0.053 0.017 DBMET02012 | DBMET02012 | |
| 0.043 | 0.154 | 0.074 | Adrenaline agonist | 0.074 0.066 DBMET02012 | DBMET02012 | |
| 0.034 | 0.145 | 0.104 | Sphingosine 1-phosphate receptor 1 antagonist | 0.104 0.008 DBMET02012 | DBMET02012 | |
| 0.031 | 0.143 | 0.096 | Glutamate receptor agonist | 0.096 0.04 DBMET02012 | DBMET02012 | |
| 0.02 | 0.132 | 0.102 | NMDA 2C receptor antagonist | 0.102 0.015 DBMET02012 | DBMET02012 | |
| 0.015 | 0.128 | 0.08 | NMDA 2A receptor antagonist | 0.08 0.02 DBMET02012 | DBMET02012 | |
| 0.03 | 0.144 | 0.073 | Acetyl-CoA transferase 2 inhibitor | 0.073 0.015 DBMET02012 | DBMET02012 | |
| 0.006 | 0.121 | 0.024 | Retinoic acid alpha receptor antagonist | 0.024 0.01 DBMET02012 | DBMET02012 | |
| 0.026 | 0.142 | 0.063 | TRPA1 antagonist | 0.063 0.04 DBMET02013 | DBMET02013 | |
| 0.004 | 0.122 | 0.054 | AMPA 1 receptor antagonist | 0.054 0.01 DBMET02012 | DBMET02012 | |
| 0.015 | 0.134 | 0.05 | AMPA receptor antagonist | 0.05 0.031 DBMET02012 | DBMET02012 | |
| 0.008 | 0.131 | 0.04 | Leukotriene B4 receptor 2 antagonist | 0.04 0.005 DBMET02012 | DBMET02012 | |
| 0.055 | 0.179 | 0.116 | Transcription factor NF kappa B stimulant | 0.116 0.027 DBMET02012 | DBMET02012 | |
| 0.097 | 0.221 | 0.239 | Antipruritic | 0.239 0.028 DBMET02012 | DBMET02012 | |
| 0.021 | 0.146 | 0.076 | Glutamate (mGluR8) antagonist | 0.076 0.004 DBMET02012 | DBMET02012 | |
| 0.117 | 0.242 | 0.599 | Hypoglycemic | 0.599 0.008 DBMET02012 0.168 0.151 DBMET02013 | DBMET02012 | |
| 0.048 | 0.179 | 0.149 | Gastric antisecretory | 0.149 0.027 DBMET02012 | DBMET02012 | |
| 0.046 | 0.179 | 0.131 | Sphingosine 1-phosphate receptor antagonist | 0.131 0.01 DBMET02012 | DBMET02012 | |
| 0.145 | 0.278 | 0.444 | Sodium/bile acid cotransporter inhibitor | 0.444 0.008 DBMET02012 0.229 0.152 DBMET02013 | DBMET02012 | |
| 0.179 | 0.314 | 0.383 | Calcium channel L-type activator | 0.383 0.093 DBMET02012 | DBMET02012 | |
| 0.007 | 0.146 | 0.081 | Glucagon receptor antagonist | 0.081 0.005 DBMET02012 | DBMET02012 | |
| 0.069 | 0.208 | 0.143 | Histone deacetylase SIRT1 inhibitor | 0.143 0.068 DBMET02012 | DBMET02012 | |
| 0.026 | 0.165 | 0.059 | HIV-1 integrase (3'-Processing) inhibitor | 0.059 0.048 DBMET02012 | DBMET02012 | |
| 0.004 | 0.145 | 0.03 | Integrin beta7 antagonist | 0.03 0.009 DBMET02012 | DBMET02012 | |
| 0.039 | 0.18 | 0.075 | Adenosine A3 receptor antagonist | 0.075 0.051 DBMET02012 | DBMET02012 | |
| 0.006 | 0.149 | 0.021 | Retinoic acid receptor antagonist | 0.021 0.01 DBMET02012 | DBMET02012 | |
| 0.023 | 0.167 | 0.081 | Prostaglandin-E synthase inhibitor | 0.081 0.038 DBMET02012 | DBMET02012 | |
| 0.004 | 0.154 | 0.142 | Free fatty acid receptor 1 agonist | 0.142 0.004 DBMET02012 | DBMET02012 | |
| 0.085 | 0.236 | 0.179 | Anticonvulsant | 0.179 0.1 DBMET02012 | DBMET02012 | |
| 0.053 | 0.206 | 0.52 | ABCA1 expression enhancer | 0.169 0.013 DBMET02012 0.52 0.003 DBMET02013 | DBMET02013 | |
| 0.065 | 0.218 | 0.127 | Toll-Like receptor antagonist | 0.127 0.075 DBMET02012 | DBMET02012 | |
| 0.11 | 0.269 | 0.237 | Thyroid hormone beta antagonist | 0.237 0.127 DBMET02012 | DBMET02012 | |
| 0.107 | 0.273 | 0.265 | Thyroid hormone antagonist | 0.265 0.114 DBMET02012 | DBMET02012 | |
| 0.053 | 0.219 | 0.171 | Lipid peroxidase inhibitor | 0.171 0.055 DBMET02012 | DBMET02012 | |
| 0.086 | 0.254 | 0.726 | Platelet antagonist | 0.726 0.005 DBMET02012 | DBMET02012 | |
| 0.017 | 0.187 | 0.064 | HIV-1 integrase (Strand Transfer) inhibitor | 0.064 0.039 DBMET02012 0.051 0.049 DBMET02013 | DBMET02012 | |
| 0.009 | 0.192 | 0.042 | Retinoid X gamma receptor antagonist | 0.042 0.004 DBMET02012 | DBMET02012 | |
| 0.015 | 0.2 | 0.105 | Neuraminidase inhibitor | 0.105 0.014 DBMET02012 0.063 0.04 DBMET02013 | DBMET02012 | |
| 0.057 | 0.242 | 0.113 | Estrogen antagonist | 0.113 0.069 DBMET02012 | DBMET02012 | |
| 0.019 | 0.206 | 0.042 | Aggrecanase 1 inhibitor | 0.042 0.023 DBMET02012 | DBMET02012 | |
| 0.024 | 0.213 | 0.081 | Angiotensin-converting enzyme inhibitor | 0.081 0.013 DBMET02012 | DBMET02012 | |
| 0.076 | 0.268 | 0.159 | P-glycoprotein inhibitor | 0.159 0.104 DBMET02012 | DBMET02012 | |
| 0.021 | 0.214 | 0.074 | Nitric oxide donor | 0.074 0.029 DBMET02012 | DBMET02012 | |
| 0.085 | 0.28 | 0.434 | Vasodilator | 0.434 0.018 DBMET02012 | DBMET02012 | |
| 0.138 | 0.333 | 0.487 | Interleukin 2 agonist | 0.487 0.01 DBMET02012 0.344 0.048 DBMET02013 | DBMET02012 | |
| 0.013 | 0.213 | 0.155 | Aldose reductase inhibitor | 0.155 0.01 DBMET02012 | DBMET02012 | |
| 0.008 | 0.208 | 0.066 | Estrogen agonist | 0.066 0.028 DBMET02012 | DBMET02012 | |
| 0.017 | 0.222 | 0.102 | Glucagon-like peptide 1 agonist | 0.102 0.021 DBMET02012 | DBMET02012 | |
| 0.007 | 0.213 | 0.073 | Prostaglandin D2 agonist | 0.073 0.004 DBMET02012 | DBMET02012 | |
| 0.005 | 0.221 | 0.104 | Vitronectin receptor antagonist | 0.104 0.005 DBMET02012 | DBMET02012 | |
| 0.024 | 0.242 | 0.098 | NMDA receptor antagonist | 0.098 0.048 DBMET02012 | DBMET02012 | |
| 0.002 | 0.223 | 0.027 | Immunosuppressant Cyclosporine-like | 0.027 0.002 DBMET02013 | DBMET02013 | |
| 0.005 | 0.242 | 0.025 | Thyroid hormone alpha agonist | 0.025 0.005 DBMET02012 | DBMET02012 | |
| 0.023 | 0.261 | 0.086 | Elastase 1 inhibitor | 0.086 0.03 DBMET02012 | DBMET02012 | |
| 0.061 | 0.303 | 0.303 | Interleukin antagonist | 0.303 0.047 DBMET02012 | DBMET02012 | |
| 0.045 | 0.291 | 0.262 | Neurotrophic factor | 0.124 0.088 DBMET02012 0.262 0.01 DBMET02013 | DBMET02013 | |
| 0.05 | 0.303 | 0.234 | 3C-Like protease (SARS coronavirus) inhibitor | 0.234 0.004 DBMET02013 | DBMET02013 | |
| 0.004 | 0.264 | 0.183 | GP IIb/IIIa receptor antagonist | 0.183 0.008 DBMET02012 | DBMET02012 | |
| 0.004 | 0.264 | 0.161 | Calpain 1 inhibitor | 0.161 0.003 DBMET02013 | DBMET02013 | |
| 0.007 | 0.274 | 0.033 | AMPA receptor agonist | 0.033 0.029 DBMET02012 | DBMET02012 | |
| 0.004 | 0.291 | 0.068 | Leukotriene B4 receptor 1 antagonist | 0.068 0.005 DBMET02012 | DBMET02012 | |
| 0.016 | 0.303 | 0.1 | CDC25B inhibitor | 0.1 0.016 DBMET02012 0.088 0.022 DBMET02013 | DBMET02012 | |
| 0.024 | 0.312 | 0.08 | HIV-1 integrase inhibitor | 0.08 0.038 DBMET02012 | DBMET02012 | |
| 0.067 | 0.364 | 0.243 | Cardiotonic | 0.243 0.087 DBMET02012 | DBMET02012 | |
| 0.012 | 0.311 | 0.09 | Estrogen-related receptor beta antagonist | 0.09 0.003 DBMET02013 | DBMET02013 | |
| 0.137 | 0.442 | 0.599 | Antiinflammatory | 0.599 0.054 DBMET02012 | DBMET02012 | |
| 0.004 | 0.339 | 0.016 | Angiotensin-converting enzyme 2 inhibitor | 0.016 0.015 DBMET02012 | DBMET02012 | |
| 0.013 | 0.35 | 0.058 | VCAM-1 antagonist | 0.058 0.005 DBMET02012 0.039 0.028 DBMET02013 | DBMET02012 | |
| 0.002 | 0.339 | 0.033 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.033 0.005 DBMET02012 | DBMET02012 | |
| 0.004 | 0.342 | 0.085 | Squalene synthetase inhibitor | 0.085 0.008 DBMET02012 | DBMET02012 | |
| 0.013 | 0.351 | 0.058 | VCAM antagonist | 0.058 0.005 DBMET02012 0.039 0.028 DBMET02013 | DBMET02012 | |
| 0.007 | 0.348 | 0.018 | Tryptophan hydroxylase 1 inhibitor | 0.018 0.01 DBMET02012 | DBMET02012 | |
| 0.005 | 0.356 | 0.025 | Integrin beta6 antagonist | 0.025 0.003 DBMET02012 | DBMET02012 | |
| 0.021 | 0.376 | 0.049 | Vanilloid 2 antagonist | 0.049 0.044 DBMET02012 | DBMET02012 | |
| 0.005 | 0.362 | 0.07 | Integrin alphaVbeta1 antagonist | 0.07 0.004 DBMET02012 | DBMET02012 | |
| 0.043 | 0.401 | 0.274 | Interleukin 4 antagonist | 0.274 0.01 DBMET02012 0.144 0.055 DBMET02013 | DBMET02012 | |
| 0.03 | 0.391 | 0.132 | Thioredoxin inhibitor | 0.132 0.024 DBMET02012 | DBMET02012 | |
| 0.005 | 0.367 | 0.081 | Integrin alphaVbeta3 antagonist | 0.081 0.004 DBMET02012 | DBMET02012 | |
| 0.025 | 0.39 | 0.09 | Aminoacyl-tRNA synthetase inhibitor | 0.09 0.058 DBMET02012 | DBMET02012 | |
| 0.01 | 0.378 | 0.145 | Plasminogen activator inhibitor antagonist | 0.145 0.005 DBMET02012 | DBMET02012 | |
| 0.034 | 0.405 | 0.181 | Dual specificity phosphatase 3 inhibitor | 0.181 0.073 DBMET02012 | DBMET02012 | |
| 0.005 | 0.384 | 0.277 | Integrin antagonist | 0.277 0.005 DBMET02012 | DBMET02012 | |
| 0.008 | 0.387 | 0.25 | Peroxisome proliferator-activated receptor gamma agonist | 0.25 0.005 DBMET02012 | DBMET02012 | |
| 0.006 | 0.394 | 0.195 | Peroxisome proliferator-activated receptor delta antagonist | 0.195 0.004 DBMET02012 | DBMET02012 | |
| 0.009 | 0.397 | 0.114 | Selectin antagonist | 0.114 0.023 DBMET02012 | DBMET02012 | |
| 0.025 | 0.419 | 0.079 | Adenine nucleotide translocase inhibitor | 0.079 0.009 DBMET02012 | DBMET02012 | |
| 0.014 | 0.408 | 0.054 | Carnitine palmitoyltransferase 1B inhibitor | 0.054 0.024 DBMET02012 | DBMET02012 | |
| 0.004 | 0.401 | 0.016 | Calcium-sensing receptor antagonist | 0.016 0.01 DBMET02012 | DBMET02012 | |
| 0.025 | 0.427 | 0.354 | Thrombolytic | 0.354 0.016 DBMET02012 | DBMET02012 | |
| 0.023 | 0.428 | 0.171 | Chelator | 0.171 0.03 DBMET02012 | DBMET02012 | |
| 0.003 | 0.41 | 0.086 | VLA-4 antagonist | 0.086 0.007 DBMET02012 | DBMET02012 | |
| 0.003 | 0.414 | 0.038 | Integrin alpha4beta7 antagonist | 0.038 0.006 DBMET02012 | DBMET02012 | |
| 0.012 | 0.425 | 0.215 | Sphingosine 1-phosphate receptor 5 agonist | 0.215 0.004 DBMET02012 | DBMET02012 | |
| 0.003 | 0.421 | 0.051 | Endothelin B receptor antagonist | 0.016 0.015 DBMET02012 0.051 0.005 DBMET02013 | DBMET02013 | |
| 0.006 | 0.428 | 0.041 | Protein kinase C beta II inhibitor | 0.041 0.01 DBMET02013 | DBMET02013 | |
| 0.003 | 0.429 | 0.05 | Thyroid hormone alpha antagonist | 0.05 0.004 DBMET02012 | DBMET02012 | |
| 0.017 | 0.444 | 0.065 | Integrin alpha1beta1 antagonist | 0.065 0.004 DBMET02012 | DBMET02012 | |
| 0.031 | 0.462 | 0.39 | Cell adhesion inhibitor | 0.39 0.005 DBMET02012 | DBMET02012 | |
| 0.004 | 0.447 | 0.079 | Leukotriene D4 antagonist | 0.079 0.007 DBMET02012 | DBMET02012 | |
| 0.028 | 0.471 | 0.188 | Dual specificity phosphatase inhibitor | 0.188 0.062 DBMET02012 | DBMET02012 | |
| 0.004 | 0.451 | 0.051 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.051 0.009 DBMET02012 | DBMET02012 | |
| 0.067 | 0.53 | 0.247 | Catenin beta inhibitor | 0.247 0.011 DBMET02012 | DBMET02012 | |
| 0.028 | 0.499 | 0.152 | Toll-Like receptor 4 antagonist | 0.152 0.02 DBMET02012 | DBMET02012 | |
| 0.008 | 0.48 | 0.228 | Protein-tyrosine phosphatase 1B inhibitor | 0.228 0.022 DBMET02012 | DBMET02012 | |
| 0.008 | 0.485 | 0.065 | p53 inhibitor | 0.065 0.007 DBMET02012 | DBMET02012 | |
| 0.002 | 0.484 | 0.04 | Neutral endopeptidase inhibitor | 0.04 0.009 DBMET02012 | DBMET02012 | |
| 0.013 | 0.495 | 0.155 | Cathepsin B inhibitor | 0.155 0.006 DBMET02013 | DBMET02013 | |
| 0.004 | 0.494 | 0.086 | Prostacyclin antagonist | 0.086 0.005 DBMET02012 | DBMET02012 | |
| 0.029 | 0.524 | 0.059 | Prolactin release inhibitor | 0.059 0.058 DBMET02012 | DBMET02012 | |
| 0.002 | 0.5 | 0.022 | Calcium-dependent phospholipase A2 inhibitor | 0.022 0.004 DBMET02012 | DBMET02012 | |
| 0.004 | 0.507 | 0.034 | Protocollagen prolyl hydroxylase inhibitor | 0.034 0.011 DBMET02012 | DBMET02012 | |
| 0.028 | 0.534 | 0.187 | MAP3K9 inhibitor | 0.187 0.022 DBMET02013 | DBMET02013 | |
| 0.047 | 0.559 | 0.638 | Growth hormone agonist | 0.638 0.003 DBMET02012 | DBMET02012 | |
| 0.003 | 0.517 | 0.019 | Endothelin A receptor antagonist | 0.019 0.017 DBMET02012 | DBMET02012 | |
| 0.015 | 0.564 | 0.069 | Trypsin inhibitor | 0.069 0.034 DBMET02013 | DBMET02013 | |
| 0.019 | 0.571 | 0.09 | DNA helicase inhibitor | 0.09 0.008 DBMET02012 | DBMET02012 | |
| 0.003 | 0.556 | 0.108 | Integrin alpha4 antagonist | 0.108 0.005 DBMET02012 | DBMET02012 | |
| 0.003 | 0.557 | 0.278 | Endothelin receptor antagonist | 0.033 0.016 DBMET02012 0.278 0.003 DBMET02013 | DBMET02013 | |
| 0.003 | 0.561 | 0.061 | Prostaglandin EP3 antagonist | 0.061 0.008 DBMET02012 | DBMET02012 | |
| 0.005 | 0.566 | 0.088 | Macrophage elastase inhibitor | 0.088 0.011 DBMET02012 | DBMET02012 | |
| 0.01 | 0.579 | 0.056 | Cholecystokinin B agonist | 0.056 0.013 DBMET02012 | DBMET02012 | |
| 0.003 | 0.573 | 0.065 | Leukotriene A4 hydrolase inhibitor | 0.065 0.013 DBMET02012 | DBMET02012 | |
| 0.006 | 0.586 | 0.068 | Integrin alpha5beta1 antagonist | 0.068 0.009 DBMET02012 | DBMET02012 | |
| 0.002 | 0.584 | 0.024 | 3C-Like protease (MERS coronavirus) inhibitor | 0.024 0.003 DBMET02013 | DBMET02013 | |
| 0.004 | 0.592 | 0.115 | Purinergic P2Y12 antagonist | 0.115 0.004 DBMET02012 | DBMET02012 | |
| 0.015 | 0.605 | 0.236 | Anticoagulant | 0.236 0.042 DBMET02012 0.123 0.108 DBMET02013 | DBMET02012 | |
| 0.01 | 0.603 | 0.046 | Neurotensin receptor antagonist | 0.046 0.031 DBMET02012 | DBMET02012 | |
| 0.036 | 0.641 | 0.229 | Folate antagonist | 0.229 0.006 DBMET02012 | DBMET02012 | |
| 0.009 | 0.616 | 0.058 | Aminopeptidase microsomal inhibitor | 0.058 0.041 DBMET02012 | DBMET02012 | |
| 0.005 | 0.615 | 0.083 | Plasmin inhibitor | 0.083 0.021 DBMET02013 | DBMET02013 | |
| 0.015 | 0.63 | 0.06 | Factor III inhibitor | 0.06 0.017 DBMET02012 | DBMET02012 | |
| 0.009 | 0.627 | 0.279 | Protein-tyrosine phosphatase inhibitor | 0.279 0.023 DBMET02012 | DBMET02012 | |
| 0.004 | 0.633 | 0.034 | Catechol O-methyltransferase inhibitor | 0.034 0.02 DBMET02012 | DBMET02012 | |
| 0.005 | 0.636 | 0.029 | NMDA 2D receptor antagonist | 0.029 0.017 DBMET02012 | DBMET02012 | |
| 0.01 | 0.645 | 0.08 | Sirtuin 1 inhibitor | 0.08 0.035 DBMET02012 | DBMET02012 | |
| 0.01 | 0.652 | 0.136 | Prostaglandin F2 alpha antagonist | 0.136 0.005 DBMET02012 | DBMET02012 | |
| 0.004 | 0.653 | 0.246 | Prostaglandin EP2 antagonist | 0.246 0.005 DBMET02012 | DBMET02012 | |
| 0.038 | 0.689 | 0.294 | Factor V inhibitor | 0.118 0.041 DBMET02012 0.294 0.002 DBMET02013 | DBMET02013 | |
| 0.013 | 0.669 | 0.159 | Glucagon-like peptide 1 receptor antagonist | 0.159 0.004 DBMET02012 | DBMET02012 | |
| 0.007 | 0.676 | 0.072 | Plasminogen activator inhibitor | 0.072 0.03 DBMET02013 | DBMET02013 | |
| 0.001 | 0.675 | 0.008 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.008 0.004 DBMET02012 0.008 0.005 DBMET02013 | DBMET02013 | |
| 0.003 | 0.678 | 0.067 | Sphingosine 1-phosphate receptor 3 agonist | 0.067 0.01 DBMET02012 0.035 0.024 DBMET02013 | DBMET02012 | |
| 0.003 | 0.678 | 0.023 | Angiotensin AT2 receptor antagonist | 0.023 0.015 DBMET02012 | DBMET02012 | |
| 0.009 | 0.686 | 0.207 | Uric acid excretion stimulant | 0.172 0.018 DBMET02012 0.207 0.012 DBMET02013 | DBMET02013 | |
| 0.005 | 0.687 | 0.098 | Analgesic, opioid | 0.098 0.032 DBMET02012 | DBMET02012 | |
| 0.006 | 0.689 | 0.079 | Maillard reaction inhibitor | 0.079 0.025 DBMET02012 | DBMET02012 | |
| 0.003 | 0.701 | 0.045 | Integrin beta5 antagonist | 0.045 0.006 DBMET02012 | DBMET02012 | |
| 0.028 | 0.73 | 0.321 | Immunomodulator | 0.321 0.071 DBMET02012 | DBMET02012 | |
| 0.011 | 0.721 | 0.083 | Factor XII inhibitor | 0.083 0.061 DBMET02013 | DBMET02013 | |
| 0.01 | 0.725 | 0.035 | HCV polyprotein inhibitor | 0.035 0.02 DBMET02012 | DBMET02012 | |
| 0.004 | 0.723 | 0.064 | Prostaglandin E2 antagonist | 0.064 0.027 DBMET02012 | DBMET02012 | |
| 0.011 | 0.732 | 0.471 | Platelet aggregation inhibitor | 0.471 0.011 DBMET02012 | DBMET02012 | |
| 0.002 | 0.746 | 0.063 | Integrin beta3 antagonist | 0.063 0.005 DBMET02012 | DBMET02012 | |
| 0.003 | 0.75 | 0.117 | Prostaglandin D2 antagonist | 0.117 0.004 DBMET02012 | DBMET02012 | |
| 0.011 | 0.771 | 0.052 | CXC chemokine 1 receptor antagonist | 0.052 0.034 DBMET02012 | DBMET02012 | |
| 0.013 | 0.778 | 0.063 | Carbonic anhydrase II stimulant | 0.063 0.02 DBMET02012 | DBMET02012 | |
| 0.004 | 0.785 | 0.26 | Prostaglandin antagonist | 0.26 0.005 DBMET02012 | DBMET02012 | |
| 0.004 | 0.801 | 0.058 | Endothelin-converting enzyme inhibitor | 0.058 0.026 DBMET02012 | DBMET02012 | |
| 0.005 | 0.805 | 0.083 | Thrombin inhibitor | 0.083 0.039 DBMET02013 | DBMET02013 | |
| 0.004 | 0.807 | 0.038 | Carbonic anhydrase I stimulant | 0.038 0.026 DBMET02012 | DBMET02012 | |
| 0.006 | 0.815 | 0.045 | Erythropoietin receptor agonist | 0.045 0.025 DBMET02012 | DBMET02012 | |
| 0.008 | 0.832 | 0.228 | Amyloid beta precursor protein antagonist | 0.228 0.042 DBMET02013 | DBMET02013 | |
| 0.003 | 0.844 | 0.066 | Complement C3a chemotactic receptor antagonist | 0.066 0.019 DBMET02012 | DBMET02012 | |
| 0.009 | 0.863 | 0.405 | Insulin secretagoues | 0.405 0.006 DBMET02012 | DBMET02012 | |
| 0.002 | 0.858 | 0.048 | Purinergic P2T antagonist | 0.048 0.01 DBMET02012 | DBMET02012 | |
| 0.008 | 0.867 | 0.379 | Toll-Like receptor 7 agonist | 0.379 0.068 DBMET02012 | DBMET02012 | |
| 0.007 | 0.873 | 0.4 | Toll-Like receptor agonist | 0.4 0.06 DBMET02012 | DBMET02012 | |
| 0.002 | 0.877 | 0.026 | Kainate receptor 3 antagonist | 0.026 0.006 DBMET02012 | DBMET02012 | |
| 0.005 | 0.886 | 0.301 | Cell adhesion molecule inhibitor | 0.301 0.005 DBMET02012 | DBMET02012 | |
| 0.003 | 0.893 | 0.029 | Liver X receptor alpha antagonist | 0.029 0.02 DBMET02012 | DBMET02012 | |
| 0.002 | 0.895 | 0.043 | Kainate receptor 4 antagonist | 0.043 0.008 DBMET02012 | DBMET02012 | |
| 0.003 | 0.901 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | 0.034 0.023 DBMET02012 | DBMET02012 | |
| 0.002 | 0.9 | 0.036 | Kainate receptor 5 antagonist | 0.036 0.008 DBMET02012 | DBMET02012 | |
| 0.01 | 0.913 | 0.143 | Nav1.4 sodium channel blocker | 0.143 0.037 DBMET02012 | DBMET02012 | |
| 0.002 | 0.914 | 0.022 | Angiotensin AT1A receptor antagonist | 0.022 0.014 DBMET02012 | DBMET02012 | |
| 0.005 | 0.926 | 0.671 | Cyclophilin D inhibitor | 0.671 0.017 DBMET02012 | DBMET02012 | |
| 0.002 | 0.939 | 0.031 | Cholecystokinin B antagonist | 0.031 0.02 DBMET02012 | DBMET02012 | |
| 0.003 | 0.944 | 0.051 | AMPA 2 receptor antagonist | 0.051 0.011 DBMET02012 | DBMET02012 | |
| 0.002 | 0.96 | 0.054 | Cholecystokinin antagonist | 0.054 0.023 DBMET02012 | DBMET02012 | |
| 0.002 | 0.965 | 0.037 | Cholecystokinin A antagonist | 0.037 0.027 DBMET02012 | DBMET02012 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |